BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Runyon BA;  AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087-2107. [PMID: 19475696 DOI: 10.1002/hep.22853] [Cited by in Crossref: 567] [Cited by in F6Publishing: 453] [Article Influence: 47.3] [Reference Citation Analysis]
Number Citing Articles
1 Borges de Santana V, Bertocco de Paiva Haddad L, Morgado Conte T, Cortez Rizzon A, Miranda Barbosa V, Shield W, Andraus W, Augusto Carneiro D’albuquerque L. MELD Score and Albumin Replacement Are Related to Higher Costs During Management of Patients With Refractory Ascites. Transplantation Proceedings 2014;46:1760-3. [DOI: 10.1016/j.transproceed.2014.05.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Pereira G, Baldin C, Piedade J, Reis V, Valdeolivas T, Victor L, Guimarães L, Duarte J, Veiga Z, Alcântara C, Fernandes F, Pereira JL. Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients. Dig Liver Dis 2020;52:91-7. [PMID: 31542220 DOI: 10.1016/j.dld.2019.08.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hsieh YC, Lee KC, Yang YY, Huo TI, Huang YH, Lin HC. Interleukin-1 receptor antagonist correlates with hepatic venous pressure gradient and predicts occurrence of overall complications and bacterial infections in patients with cirrhosis. Hepatol Res. 2014; May 14. [Epub ahead of print]. [PMID: 24826996 DOI: 10.1111/hepr.12355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Gianotti RJ, Cardenas A. Hyponatraemia and cirrhosis. Gastroenterol Rep (Oxf) 2014;2:21-6. [PMID: 24760233 DOI: 10.1093/gastro/got037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
5 Acevedo J. Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies. World J Hepatol 2015; 7(7): 916-921 [PMID: 25954474 DOI: 10.4254/wjh.v7.i7.916] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
6 Guacho JAL, de Moura DTH, Ribeiro IB, da Ponte Neto AM, Singh S, Tucci MGB, Bernardo WM, de Moura EGH. Propofol vs midazolam sedation for elective endoscopy in patients with cirrhosis: A systematic review and meta-analysis of randomized controlled trials. World J Gastrointest Endosc 2020; 12(8): 241-255 [PMID: 32879659 DOI: 10.4253/wjge.v12.i8.241] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Mindikoglu AL, Pappas SC. New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol 2018;16:162-177.e1. [PMID: 28602971 DOI: 10.1016/j.cgh.2017.05.041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
8 Schmid S, Wiest R, Salzberger B, Klebl F. Spontan bakterielle Peritonitis. Med Klin Intensivmed Notfmed 2012;107:548-52. [DOI: 10.1007/s00063-012-0084-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Colombo BD, Ronsoni MF, Soares E Silva PE, Fayad L, Wildner LM, Bazzo ML, Dantas-Correa EB, Narciso-Schiavon JL, Schiavon LL. Prognostic significance of insulin-like growth factor-I serum levels in acute decompensation of cirrhosis. Biomarkers 2017;22:127-32. [PMID: 27775431 DOI: 10.1080/1354750X.2016.1252949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Miozzo SAS, John JA, Appel-da-Silva MC, Dossin IA, Tovo CV, Mattos AA. Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis. World J Hepatol 2017; 9(35): 1278-1285 [PMID: 29290909 DOI: 10.4254/wjh.v9.i35.1278] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
11 Padovan M, Filippini M, Tincani A, Lanciano E, Bruschi E, Epis O, Garau P, Mathieu A, Celletti E, Giani L, Tomietto P, Atzeni F, Sarzi Puttini P, Zuliani F, De Vita S, Trotta F, Grilli A, Puoti M, Govoni M. Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection. Arthritis Care Res (Hoboken) 2016;68:738-43. [PMID: 26555747 DOI: 10.1002/acr.22786] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
12 Louissaint J, Lok AS, Fortune BE, Tapper EB. Acceptance and use of a smartphone application in cirrhosis. Liver Int 2020;40:1556-63. [DOI: 10.1111/liv.14494] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
13 Jamtgaard L, Manning SL, Cohn B. Does Albumin Infusion Reduce Renal Impairment and Mortality in Patients With Spontaneous Bacterial Peritonitis? Ann Emerg Med 2016;67:458-9. [PMID: 26234193 DOI: 10.1016/j.annemergmed.2015.07.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
14 Lane ER, Hsu EK, Murray KF. Management of ascites in children. Expert Review of Gastroenterology & Hepatology 2015;9:1281-92. [DOI: 10.1586/17474124.2015.1083419] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
15 Buoro S, Appassiti Esposito S, Vavassori M, Mecca T, Ottomano C, Dominoni P, Seghezzi M, Candiago E, Farina C, Gianatti A, Crippa A, Lippi G. Reflex Testing Rules for Cell Count and Differentiation of Nucleated Elements in Pleural and Ascitic Fluids on Sysmex XE-5000. J Lab Autom 2016;21:297-304. [DOI: 10.1177/2211068215593375] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
16 Tan HH, Martin P. Management of end-stage liver disease in chronic hepatitis B. Clin Liver Dis. 2010;14:477-493. [PMID: 20638026 DOI: 10.1016/j.cld.2010.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
17 Leifeld L, Denzer U, Frieling T, Jakobs R, Koop H, van Leeuwen P, Madisch A, Rosien U, Stier A, Siegmund B, Tappe U, Lammert F, Lynen Jansen P. [Quality management in the field of gastroenterology - Proposals of the Quality Commission of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) for Outpatient and Inpatient Quality Assurance]. Z Gastroenterol 2021;59:665-76. [PMID: 34255315 DOI: 10.1055/a-1451-6350] [Reference Citation Analysis]
18 Moreau R, Elkrief L, Bureau C, Perarnau J, Thévenot T, Saliba F, Louvet A, Nahon P, Lannes A, Anty R, Hillaire S, Pasquet B, Ozenne V, Rudler M, Ollivier-hourmand I, Robic MA, d'Alteroche L, Di Martino V, Ripault M, Pauwels A, Grangé J, Carbonell N, Bronowicki J, Payancé A, Rautou P, Valla D, Gault N, Lebrec D. Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis. Gastroenterology 2018;155:1816-1827.e9. [DOI: 10.1053/j.gastro.2018.08.026] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 17.7] [Reference Citation Analysis]
19 Desai AP, Satoskar R, Appannagari A, Reddy KG, Te HS, Reau N, Meltzer DO, Jensen D. Co-management between hospitalist and hepatologist improves the quality of care of inpatients with chronic liver disease. J Clin Gastroenterol. 2014;48:e30-e36. [PMID: 24100752 DOI: 10.1097/MCG.0b013e3182a87f70] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
20 Brown CL, Hammill BG, Qualls LG, Curtis LH, Muir AJ. Significant Morbidity and Mortality Among Hospitalized End-Stage Liver Disease Patients in Medicare. J Pain Symptom Manage 2016;52:412-419.e1. [PMID: 27265812 DOI: 10.1016/j.jpainsymman.2016.03.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
21 Acevedo J, Fernández J. New determinants of prognosis in bacterial infections in cirrhosis. World J Gastroenterol 2014; 20(23): 7252-7259 [PMID: 24966596 DOI: 10.3748/wjg.v20.i23.7252] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
22 Sutton SS, Jumper M, Shah A, Edun B. Clostridium tertium Peritonitis and Concurrent Bacteremia in a Patient With a History of Alcoholic Cirrhosis. J Investig Med High Impact Case Rep 2017;5:2324709617731457. [PMID: 28944228 DOI: 10.1177/2324709617731457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Li K, Neuberger J. The management of patients awaiting liver transplantation. Nat Rev Gastroenterol Hepatol 2009;6:648-59. [DOI: 10.1038/nrgastro.2009.163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Sharzehi K, Jain V, Naveed A, Schreibman I. Hemorrhagic complications of paracentesis: a systematic review of the literature. Gastroenterol Res Pract 2014;2014:985141. [PMID: 25580114 DOI: 10.1155/2014/985141] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
25 Bunchorntavakul C, Chavalitdhamrong D. Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. World J Hepatol 2012; 4(5): 158-168 [PMID: 22662285 DOI: 10.4254/wjh.v4.i5.158] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
26 Acevedo JG, Cramp ME. Hepatorenal syndrome: Update on diagnosis and therapy. World J Hepatol 2017; 9(6): 293-299 [PMID: 28293378 DOI: 10.4254/wjh.v9.i6.293] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
27 赵莹莹, 邢卉春. 基于不同引物的16S rRNA序列分析法对SBP腹水细菌的鉴定及抗感染疗效评价的意义. 世界华人消化杂志 2015; 23(29): 4713-4719 [DOI: 10.11569/wcjd.v23.i29.4713] [Reference Citation Analysis]
28 Adebayo D, Neong SF, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol. 2018;. [PMID: 29973706 DOI: 10.1038/s41395-018-0185-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
29 Reuken PA, Pletz MW, Baier M, Pfister W, Stallmach A, Bruns T. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther. 2012;35:1199-1208. [PMID: 22449290 DOI: 10.1111/j.1365-2036.2012.05076.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
30 Dirchwolf M, Marciano S, Martínez J, Ruf AE. Unresolved issues in the prophylaxis of bacterial infections in patients with cirrhosis. World J Hepatol 2018; 10(12): 892-897 [PMID: 30631393 DOI: 10.4254/wjh.v10.i12.892] [Reference Citation Analysis]
31 Kong Z, Liang N, Yang GL, Zhang Z, Liu Y, Yang Y, Liu YX, Wang QG, Zhang F, Zhang HY, Nikolova D, Jakobsen JC, Gluud C, Liu JP. Acupuncture for chronic hepatitis B. Cochrane Database Syst Rev 2019;8:CD013107. [PMID: 31436846 DOI: 10.1002/14651858.CD013107.pub2] [Reference Citation Analysis]
32 Flamm SL, Brown K, Wadei HM, Brown RS Jr, Kugelmas M, Samaniego-Picota M, Burra P, Poordad F, Saab S. The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin. Liver Transpl 2021;27:1191-202. [PMID: 33848394 DOI: 10.1002/lt.26072] [Reference Citation Analysis]
33 Engelmann C, Berg T. Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure. Visc Med. 2018;34:261-268. [PMID: 30345283 DOI: 10.1159/000491107] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
34 Liu J, Zhou B, Chen D, Zhou C, Shi Q, Zheng C, Feng G, Yuan F, Ge Y, Xiong B. Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis. Cardiovasc Intervent Radiol 2019;42:1760-70. [PMID: 31363898 DOI: 10.1007/s00270-019-02295-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
35 Boglione L, D'avolio A, Cariti G, Milia MG, Simiele M, De Nicolò A, Ghisetti V, Di Perri G. Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes. J Viral Hepat 2013;20:e11-9. [DOI: 10.1111/jvh.12018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
36 Hansen JD, Perri RE, Riess ML. Liver and Biliary Disease of Pregnancy and Anesthetic Implications: A Review. Anesth Analg 2021;133:80-92. [PMID: 33687174 DOI: 10.1213/ANE.0000000000005433] [Reference Citation Analysis]
37 Morando F, Maresio G, Piano S, Fasolato S, Cavallin M, Romano A, Rosi S, Gola E, Frigo AC, Stanco M, Destro C, Rupolo G, Mantoan D, Gatta A, Angeli P. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol. 2013;59:257-264. [PMID: 23523582 DOI: 10.1016/j.jhep.2013.03.010] [Cited by in Crossref: 104] [Cited by in F6Publishing: 86] [Article Influence: 13.0] [Reference Citation Analysis]
38 Tan HK, James PD, Wong F. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study. Dig Dis Sci 2016;61:3084-92. [DOI: 10.1007/s10620-016-4140-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
39 Mirici-Cappa F, Caraceni P, Domenicali M, Gelonesi E, Benazzi B, Zaccherini G, Trevisani F, Puggioli C, Bernardi M. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol 2011; 17(30): 3479-3486 [PMID: 21941414 DOI: 10.3748/wjg.v17.i30.3479] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
40 Wiegand J, Kühne M, Pradat P, Mössner J, Trepo C, Tillmann HL. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis. Aliment Pharmacol Ther. 2012;35:1443-1450. [PMID: 22530565 DOI: 10.1111/j.1365-2036.2012.05108.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
41 Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013;58:1836-1846. [PMID: 23423799 DOI: 10.1002/hep.26338] [Cited by in Crossref: 189] [Cited by in F6Publishing: 152] [Article Influence: 23.6] [Reference Citation Analysis]
42 Bezjak M, Kocman B, Jadrijević S, Gašparović H, Mrzljak A, Kanižaj TF, Vujanić D, Bubalo T, Mikulić D. Constrictive pericarditis as a cause of refractory ascites after liver transplantation: A case report. World J Clin Cases 2019; 7(20): 3266-3270 [PMID: 31667177 DOI: 10.12998/wjcc.v7.i20.3266] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 García Buey L, González Mateos F, Moreno-otero R. Cirrosis hepática. Medicine - Programa de Formación Médica Continuada Acreditado 2012;11:625-33. [DOI: 10.1016/s0304-5412(12)70359-1] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
44 Hsiang JC, Gane EJ, Bai WW, Gerred SJ. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol. 2015;30:591-599. [PMID: 25250942 DOI: 10.1111/jgh.12790] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
45 Sadick V, Bowcock E, Lane S, Seppelt I. Survival and predictors of outcome among patients with decompensated liver disease in a non-liver transplant intensive care unit. Pessimism is historical and unjustified. Intern Med J 2019;49:745-52. [PMID: 30379403 DOI: 10.1111/imj.14151] [Reference Citation Analysis]
46 Yan K, Garcia-Tsao G. Novel prevention strategies for bacterial infections in cirrhosis. Expert Opin Pharmacother. 2016;17:689-701. [PMID: 26799197 DOI: 10.1517/14656566.2016.1145663] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
47 Kwok CS, Krupa L, Mahtani A, Kaye D, Rushbrook SM, Phillips MG, Gelson W. Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis. Biomed Res Int 2013;2013:295153. [PMID: 24222902 DOI: 10.1155/2013/295153] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
48 Bremmer DN, Garavaglia JM, Shields RK. Spontaneous fungal peritonitis: a devastating complication of cirrhosis. Mycoses. 2015;58:387-393. [PMID: 25851525 DOI: 10.1111/myc.12321] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
49 Muir AJ. Understanding the Complexities of Cirrhosis. Clinical Therapeutics 2015;37:1822-36. [DOI: 10.1016/j.clinthera.2015.05.507] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
50 Acevedo J, Prado V, Fernández J. Changing options for prevention and treatment of infections in cirrhosis. Curr Treat Options Gastroenterol. 2014;12:256-267. [PMID: 24705946 DOI: 10.1007/s11938-014-0017-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
51 de Jonge R, Brouwer R, de Graaf MT, Luitwieler RL, Fleming C, de Frankrijker-merkestijn M, Sillevis Smitt PA, Boonstra JG, Lindemans J. Evaluation of the new body fluid mode on the Sysmex XE-5000 for counting leukocytes and erythrocytes in cerebrospinal fluid and other body fluids. Clinical Chemistry and Laboratory Medicine 2010;48. [DOI: 10.1515/cclm.2010.108] [Cited by in Crossref: 43] [Cited by in F6Publishing: 7] [Article Influence: 3.9] [Reference Citation Analysis]
52 Yamada T, Ohki T, Hayata Y, Karasawa Y, Kawamura S, Ito D, Kojima K, Seki M, Toda N, Tagawa K. Potential Effectiveness of Tolvaptan to Improve Ascites Unresponsive to Standard Diuretics and Overall Survival in Patients with Decompensated Liver Cirrhosis. Clin Drug Investig 2016;36:829-35. [DOI: 10.1007/s40261-016-0434-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
53 Garcia-tsao G. Ascites. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 283-95. [DOI: 10.1016/b978-1-4377-0881-3.00018-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Gálvez-Martínez M, Servín-Caamaño AI, Pérez-Torres E, Salas-Gordillo F, Rivera-Gutiérrez X, Higuera-de la Tijera F. Mean platelet volume as a novel predictor of systemic inflammatory response in cirrhotic patients with culture-negative neutrocytic ascites. World J Hepatol 2015; 7(7): 1001-1006 [PMID: 25954482 DOI: 10.4254/wjh.v7.i7.1001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Shi L, Wu D, Wei L, Liu S, Zhao P, Tu B, Xie Y, Liu Y, Wang X, Liu L. Nosocomial and Community-Acquired Spontaneous Bacterial Peritonitis in patients with liver cirrhosis in China: Comparative Microbiology and Therapeutic Implications. Sci Rep. 2017;7:46025. [PMID: 28382951 DOI: 10.1038/srep46025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
56 Bhattacharya C, Das-Mondal M, Gupta D, Sarkar AK, Kar-Purkayastha S, Konar A. Infection in cirrhosis: A prospective study. Ann Hepatol 2019;18:862-8. [PMID: 31635968 DOI: 10.1016/j.aohep.2019.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Khungar V, Saab S. Cirrhosis With Refractory Ascites: Serial Large Volume Paracentesis, TIPS, or Transplantation? Clinical Gastroenterology and Hepatology 2011;9:931-5. [DOI: 10.1016/j.cgh.2011.04.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
58 Rogers GB, van der Gast CJ, Bruce KD, Marsh P, Collins JE, Sutton J, Wright M. Ascitic microbiota composition is correlated with clinical severity in cirrhosis with portal hypertension. PLoS One. 2013;8:e74884. [PMID: 24086392 DOI: 10.1371/journal.pone.0074884] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
59 Guo C, Guo G, Zhou X, Chen Y, Han Z, Yang C, Zhao S, Su H, Lian Z, Leung PSC, Gershwin ME, Zhou X, Han Y. Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Patients With Cirrhosis. Clin Gastroenterol Hepatol 2019;17:1175-1182.e2. [PMID: 30613001 DOI: 10.1016/j.cgh.2018.10.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Sakaida I, Yamashita S, Kobayashi T, Komatsu M, Sakai T, Komorizono Y, Okada M, Okita K; ASCITES 14-Day Administration Study Group. Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema. J Int Med Res. 2013;41:835-847. [PMID: 23685892 DOI: 10.1177/0300060513480089] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
61 Gordon FD. Ascites. Clin Liver Dis. 2012;16:285-299. [PMID: 22541699 DOI: 10.1016/j.cld.2012.03.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
62 Morando F, Rosi S, Gola E, Nardi M, Piano S, Fasolato S, Stanco M, Cavallin M, Romano A, Sticca A, Caregaro L, Gatta A, Angeli P. Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. Liver Int. 2015;35:1508-1515. [PMID: 24811138 DOI: 10.1111/liv.12583] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
63 Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113:175-194. [PMID: 29336434 DOI: 10.1038/ajg.2017.469] [Cited by in Crossref: 205] [Cited by in F6Publishing: 174] [Article Influence: 68.3] [Reference Citation Analysis]
64 Sharfuddin AA, Weisbord SD, Palevsky PM, Molitoris BA. Acute Kidney Injury. Brenner and Rector's The Kidney. Elsevier; 2012. pp. 1044-99. [DOI: 10.1016/b978-1-4160-6193-9.10030-2] [Cited by in Crossref: 11] [Article Influence: 1.2] [Reference Citation Analysis]
65 Schmidt ML, Barritt AS, Orman ES, Hayashi PH. Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology. 2015;148:967-977.e2. [PMID: 25623044 DOI: 10.1053/j.gastro.2015.01.032] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 13.5] [Reference Citation Analysis]
66 Li H, Sun Z, Odo N, Keshavamurthy JH, Agarwal S. Effect of large volume paracentesis performed just prior to transjugular intrahepatic portosystemic shunt on the anesthetic management during the procedure. J Anaesthesiol Clin Pharmacol 2021;37:43-6. [PMID: 34103821 DOI: 10.4103/joacp.JOACP_265_19] [Reference Citation Analysis]
67 Castillo AM, Natkowski J, Rubal-Peace G. Assessing adherence to current national guidelines for appropriate albumin use at an academic medical center. Pharm Pract (Granada) 2018;16:1190. [PMID: 30023030 DOI: 10.18549/PharmPract.2018.02.1190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA. AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology 2013;58:2142-52. [PMID: 23775835 DOI: 10.1002/hep.26578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
69 Maraolo AE, Gentile I, Pinchera B, Nappa S, Borgia G. Current and emerging pharmacotherapy for the treatment of bacterial peritonitis. Expert Opin Pharmacother 2018;19:1317-25. [PMID: 30071176 DOI: 10.1080/14656566.2018.1505867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
70 Goodman BM 3rd, Boggs JP, Tahhan SG, Ryal JL, Chen IA. Infectious disease emergencies: frontline clinical pearls. Med Clin North Am 2012;96:1033-66. [PMID: 23102476 DOI: 10.1016/j.mcna.2012.09.001] [Reference Citation Analysis]
71 Zhao R, Lu J, Shi Y, Zhao H, Xu K, Sheng J. Current management of refractory ascites in patients with cirrhosis. J Int Med Res 2018;46:1138-45. [PMID: 29210304 DOI: 10.1177/0300060517735231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
72 Bañares R, Bernardi M. Long-term albumin administration in patients with decompensated cirrhosis. It is time for a reappraisal. Liver Int 2019;39:45-8. [DOI: 10.1111/liv.13996] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
73 Wang H, Li Y, Zhang F, Yang N, Xie N, Mao Y, Li B. Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients. BMC Infect Dis 2018;18:389. [PMID: 30097024 DOI: 10.1186/s12879-018-3308-1] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Yosry A, Soliman ZA, Eletreby R, Hamza I, Ismail A, Elkady MA. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study. European Journal of Gastroenterology & Hepatology 2019;31:345-51. [DOI: 10.1097/meg.0000000000001277] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
75 Bhogal H, Sanyal AJ. Treatment of refractory ascites. Clin Liver Dis. 2013;2:140-142. [PMID: 30992847 DOI: 10.1002/cld.211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Stepanova M, Nader F, Bureau C, Adebayo D, Elkrief L, Valla D, Peck-radosavljevic M, Mccune A, Vargas V, Simon-talero M, Cordoba J, Angeli P, Rossi S, Macdonald S, Capel J, Jalan R, Younossi ZM. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study. Qual Life Res 2018;27:1513-20. [DOI: 10.1007/s11136-018-1813-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
77 Aguirre Valadez JM, Rivera-Espinosa L, Méndez-Guerrero O, Chávez-Pacheco JL, García Juárez I, Torre A. Intestinal permeability in a patient with liver cirrhosis. Ther Clin Risk Manag 2016;12:1729-48. [PMID: 27920543 DOI: 10.2147/TCRM.S115902] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
78 Kurup AN, Lekah A, Reardon ST, Schmit GD, Mcdonald JS, Carter RE, Kamath PS, Callstrom MR, Atwell TD. Bleeding Rate for Ultrasound-Guided Paracentesis in Thrombocytopenic Patients. Journal of Ultrasound in Medicine 2015;34:1833-8. [DOI: 10.7863/ultra.14.10034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
79 Segarra-Newnham M, Henneman A. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding. Ann Pharmacother. 2010;44:1946-1954. [PMID: 21098755 DOI: 10.1345/aph.1p317] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
80 Hartleb M, Gutkowski K. Kidneys in chronic liver diseases. World J Gastroenterol 2012; 18(24): 3035-3049 [PMID: 22791939 DOI: 10.3748/wjg.v18.i24.3035] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
81 Cadranel JF, Nousbaum JB, Bessaguet C, Nahon P, Nguyen-Khac E, Moreau R, Thévenot T, Silvain C, Bureau C, Nouel O, Pilette C, Paupard T, Pauwels A, Sapey T, Grangé JD, Tran A. Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients. World J Hepatol 2013; 5(3): 104-108 [PMID: 23556041 DOI: 10.4254/wjh.v5.i3.104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
82 Guevara M, Terra C, Nazar A, Solà E, Fernández J, Pavesi M, Arroyo V, Ginès P. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J Hepatol. 2012;57:759-765. [PMID: 22732511 DOI: 10.1016/j.jhep.2012.06.013] [Cited by in Crossref: 119] [Cited by in F6Publishing: 90] [Article Influence: 13.2] [Reference Citation Analysis]
83 Liu P, Hum J, Jou J, Scanlan RM, Shatzel J. Transfusion strategies in patients with cirrhosis. Eur J Haematol 2020;104:15-25. [PMID: 31661175 DOI: 10.1111/ejh.13342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
84 Ekpanyapong S, Reddy KR. Infections in Cirrhosis. Curr Treat Options Gastroenterol. 2019;17:254-270. [PMID: 30980335 DOI: 10.1007/s11938-019-00229-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
85 Bloom S, Kemp W, Lubel J. Portal hypertension: pathophysiology, diagnosis and management: Portal hypertension current concepts. Intern Med J 2015;45:16-26. [DOI: 10.1111/imj.12590] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
86 Attallah AM, Abdallah SO, El-Desouky MA, El-Far M, Omran MM, Farid K, Abdelrazek MA, Shabaka MN, Zaghloul H, Fawzy AM, Bazeed FB. A rapid, low-cost quantitative diagnostic method for hepatitis C virus infection using capillary zone electrophoresis. Eur J Clin Microbiol Infect Dis 2014;33:439-52. [PMID: 24253493 DOI: 10.1007/s10096-013-1976-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
87 Runyon BA. A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm. Int J Hepatol. 2011;2011:801983. [PMID: 22121492 DOI: 10.4061/2011/801983] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
88 Volk ML, Fisher N, Fontana RJ. Patient knowledge about disease self-management in cirrhosis. Am J Gastroenterol 2013;108:302-5. [PMID: 23459041 DOI: 10.1038/ajg.2012.214] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 6.9] [Reference Citation Analysis]
89 Li YT, Huang JR, Peng ML. Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis. Biomed Res Int 2020;2020:3743962. [PMID: 32724800 DOI: 10.1155/2020/3743962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:727-738. [PMID: 21397731 DOI: 10.1016/j.cgh.2011.02.031] [Cited by in Crossref: 177] [Cited by in F6Publishing: 167] [Article Influence: 17.7] [Reference Citation Analysis]
91 Farias AQ, Silvestre OM, Garcia-tsao G, da Costa Seguro LF, de Campos Mazo DF, Bacal F, Andrade JL, Gonçalves LL, Strunz C, Ramos DS, Polli D, Pugliese V, Rodrigues AC, Furtado MS, Carrilho FJ, D'albuquerque LA. Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: A diagnostic accuracy study: Hepatology. Hepatology 2014;59:1043-51. [DOI: 10.1002/hep.26643] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
92 Yoon JH, Jun CH, Kim JH, Yoon EL, Kim BS, Song JE, Suk KT, Kim MY, Kang SH. Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol. J Korean Med Sci 2021;36:e145. [PMID: 34060260 DOI: 10.3346/jkms.2021.36.e145] [Reference Citation Analysis]
93 Ariza X, Castellote J, Lora-Tamayo J, Girbau A, Salord S, Rota R, Ariza J, Xiol X. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol. 2012;56:825-832. [PMID: 22173153 DOI: 10.1016/j.jhep.2011.11.010] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 10.0] [Reference Citation Analysis]
94 Bukur M, Felder SI, Singer MB, Ley EJ, Malinoski DJ, Margulies DR, Salim A. Trauma center level impacts survival for cirrhotic trauma patients. J Trauma Acute Care Surg 2013;74:1133-7. [PMID: 23511156 DOI: 10.1097/TA.0b013e3182858a59] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
95 Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GB. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Rev Qual Life Cancer Care 2016;1:231-8. [PMID: 30906877 DOI: 10.1080/23809000.2016.1185369] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
96 Erly B, Carey WD, Kapoor B, McKinney JM, Tam M, Wang W. Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options. Semin Intervent Radiol. 2015;32:445-454. [PMID: 26622108 DOI: 10.1055/s-0035-1564794] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
97 Choi H, Kim Y, Kim SM, Shin J, Jang HR, Lee JE, Huh W, Kim YG, Oh HY, Kim DJ. Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT. Kidney Res Clin Pract 2012;31:106-11. [PMID: 26889416 DOI: 10.1016/j.krcp.2012.04.317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
98 Lahmer T, Brandl A, Rasch S, Schmid RM, Huber W. Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis. PLoS One 2016;11:e0158389. [PMID: 27390856 DOI: 10.1371/journal.pone.0158389] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
99 Pinchot JW, Kalva SP, Majdalany BS, Kim CY, Ahmed O, Asrani SK, Cash BD, Eldrup-Jorgensen J, Kendi AT, Scheidt MJ, Sella DM, Dill KE, Hohenwalter EJ; Expert Panels on Interventional Radiology and Vascular Imaging. ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension. J Am Coll Radiol 2021;18:S153-73. [PMID: 33958110 DOI: 10.1016/j.jacr.2021.02.013] [Reference Citation Analysis]
100 Carrion AF, Martin P. When to Refer for Liver Transplantation. Am J Gastroenterol 2019;114:7-10. [PMID: 30171217 DOI: 10.1038/s41395-018-0242-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Hanouneh MA, Hanouneh IA, Hashash JG, Law R, Esfeh JM, Lopez R, Hazratjee N, Smith T, Zein NN. The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis. J Clin Gastroenterol. 2012;46:709-715. [PMID: 22878533 DOI: 10.1097/mcg.0b013e3182506dbb] [Cited by in Crossref: 65] [Cited by in F6Publishing: 21] [Article Influence: 8.1] [Reference Citation Analysis]
102 Bolia R, Srivastava A, Marak R, Yachha SK, Poddar U. Prevalence and Impact of Bacterial Infections in Children With Liver Disease-A Prospective Study. J Clin Exp Hepatol 2018;8:35-41. [PMID: 29743795 DOI: 10.1016/j.jceh.2017.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Tyson CC, Nwankwo C, Lin PH, Svetkey LP. The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations. Curr Hypertens Rep. 2012;14:388-396. [PMID: 22846984 DOI: 10.1007/s11906-012-0296-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
104 Block DR, Algeciras-schimnich A. Body fluid analysis: Clinical utility and applicability of published studies to guide interpretation of today’s laboratory testing in serous fluids. Critical Reviews in Clinical Laboratory Sciences 2013;50:107-24. [DOI: 10.3109/10408363.2013.844679] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
105 McCarty TR, Njei B. Self-expanding metal stents for acute refractory esophageal variceal bleeding: A systematic review and meta-analysis. Dig Endosc. 2016;28:539-547. [PMID: 26845490 DOI: 10.1111/den.12626] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 5.4] [Reference Citation Analysis]
106 Mansour D, Mcpherson S. Management of decompensated cirrhosis. Clin Med 2018;18:s60-5. [DOI: 10.7861/clinmedicine.18-2-s60] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
107 Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749-1761. [PMID: 24480518 DOI: 10.1016/s0140-6736(14)60121-5] [Cited by in Crossref: 801] [Cited by in F6Publishing: 395] [Article Influence: 114.4] [Reference Citation Analysis]
108 Kadam N, Acharya S, Shukla S, Gupta K. Ascitic Fluid High Sensitive C-Reactive Protein (hs-CRP). A Prognostic Marker in Cirrhosis with Spontaneous Bacterial Peritonitis. J Clin Diagn Res. 2016;10:OC20-OC24. [PMID: 27190862 DOI: 10.7860/jcdr/2016/17931.7610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
109 Bernardi M, Caraceni P, Navickis RJ. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis? Expert Rev Gastroenterol Hepatol. 2017;11:191-192. [PMID: 28004601 DOI: 10.1080/17474124.2017.1275961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
110 Zhang J, Yu WQ, Chen W, Wei T, Wang CW, Zhang JY, Zhang Y, Liang TB. Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Anti-Enterococcal Therapy for Intra-Abdominal Infection. Surg Infect (Larchmt) 2021;22:131-43. [PMID: 32471332 DOI: 10.1089/sur.2020.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Shi K, Fan Y, Ying L, Lin X, Song M, Li L, Yu X, Chen Y, Zheng M. Risk stratification of spontaneous bacterial peritonitis in cirrhosis with ascites based on classification and regression tree analysis. Mol Biol Rep 2012;39:6161-9. [DOI: 10.1007/s11033-011-1432-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
112 Narahara Y, Kanazawa H, Fukuda T, Matsushita Y, Harimoto H, Kidokoro H, Katakura T, Atsukawa M, Taki Y, Kimura Y, Nakatsuka K, Sakamoto C. Transjugular intrahepatic portosystemic shunt vs paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol. 2011;46:78-85. [PMID: 20632194 DOI: 10.1007/s00535-010-0282-9] [Cited by in Crossref: 90] [Cited by in F6Publishing: 76] [Article Influence: 8.2] [Reference Citation Analysis]
113 Attar BM, Moore CM, George M, Ion-Nedelcu N, Turbay R, Zachariah A, Ramadori G, Fareed J, Thiel DHV. Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites. World J Gastroenterol 2014; 20(9): 2374-2382 [PMID: 24605035 DOI: 10.3748/wjg.v20.i9.2374] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
114 Calik Basaran N, Ascioglu S. Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature. Ther Adv Infect Dis 2017;4:171-91. [PMID: 29662673 DOI: 10.1177/2049936117733394] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Devarbhavi H, Rao P, Patil M, Adarsh CK. Characteristics of Ascites in Patients With Pregnancy-Specific Liver Diseases. Clinical Gastroenterology and Hepatology 2012;10:559-62. [DOI: 10.1016/j.cgh.2011.11.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
116 Ning NZ, Li T, Zhang JL, Qu F, Huang J, Liu X, Li Z, Geng W, Fu JL, Huan W, Zhang SY, Bao CM, Wang H. Clinical and bacteriological features and prognosis of ascitic fluid infection in Chinese patients with cirrhosis. BMC Infect Dis 2018;18:253. [PMID: 29866104 DOI: 10.1186/s12879-018-3101-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
117 Alsebaey A, Rewisha E, Waked I. Paracentesis-induced circulatory dysfunction: are there albumin alternatives? Egypt Liver Journal 2020;10. [DOI: 10.1186/s43066-020-00047-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Kanwal F, El-Serag H. Improving quality of care in patients with cirrhosis. Clin Liver Dis (Hoboken) 2013;2:123-4. [PMID: 30992842 DOI: 10.1002/cld.189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
119 Paine CH, Biggins SW, Pichler RH. Albumin in Cirrhosis: More Than a Colloid. Curr Treat Options Gastro 2019;17:231-43. [DOI: 10.1007/s11938-019-00227-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
120 Fernández J, Tandon P, Mensa J, Garcia-tsao G. Antibiotic prophylaxis in cirrhosis: Good and bad. Hepatology 2016;63:2019-31. [DOI: 10.1002/hep.28330] [Cited by in Crossref: 96] [Cited by in F6Publishing: 77] [Article Influence: 19.2] [Reference Citation Analysis]
121 Buoro S, Mecca T, Azzarà G, Seghezzi M, Dominoni P, Crippa A, Ottomano C, Lippi G. Cell Population Data and reflex testing rules of cell analysis in pleural and ascitic fluids using body fluid mode on Sysmex XN-9000. Clin Chim Acta 2016;452:92-8. [PMID: 26554518 DOI: 10.1016/j.cca.2015.11.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
122 Mahdavi JJ, Aliasl J, Ehsani MJ, Kamalinejad M, Gachkar L, Choopani R. Traditional Iranian medicine: The use of the Canon of medicine by Avicenna to treat ascites. European Journal of Integrative Medicine 2015;7:674-8. [DOI: 10.1016/j.eujim.2015.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
123 Piano S, Fasolato S, Salinas F, Romano A, Tonon M, Morando F, Cavallin M, Gola E, Sticca A, Loregian A, Palù G, Zanus G, Senzolo M, Burra P, Cillo U, Angeli P. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial: HEPATOLOGY, Vol. XX, No. X, 2015 PIANO ET AL. Hepatology 2016;63:1299-309. [DOI: 10.1002/hep.27941] [Cited by in Crossref: 107] [Cited by in F6Publishing: 81] [Article Influence: 17.8] [Reference Citation Analysis]
124 Enzler MJ, Berbari E, Osmon DR. Antimicrobial prophylaxis in adults. Mayo Clin Proc 2011;86:686-701. [PMID: 21719623 DOI: 10.4065/mcp.2011.0012] [Cited by in Crossref: 98] [Cited by in F6Publishing: 60] [Article Influence: 9.8] [Reference Citation Analysis]
125 Nanda A, Reddy R, Safraz H, Salameh H, Singal AK. Pharmacological Therapies for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2018;52:360-7. [PMID: 28991106 DOI: 10.1097/MCG.0000000000000913] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
126 Zhao Q, Xing F, Tao Y, Liu H, Huang K, Peng Y, Feng N, Liu C. Xiaozhang Tie Improves Intestinal Motility in Rats With Cirrhotic Ascites by Regulating the Stem Cell Factor/c-kit Pathway in Interstitial Cells of Cajal. Front Pharmacol 2020;11:1. [PMID: 32116689 DOI: 10.3389/fphar.2020.00001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 30.0] [Reference Citation Analysis]
127 Hanai T, Shiraki M, Miwa T, Watanabe S, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis. Hepatol Res 2019;49:82-95. [PMID: 30156741 DOI: 10.1111/hepr.13244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
128 Krajina A, Hulek P, Fejfar T, Valek V. Quality improvement guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS). Cardiovasc Intervent Radiol. 2012;35:1295-1300. [PMID: 23070105 DOI: 10.1007/s00270-012-0493-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
129 Muley M, Vespasiani-Gentilucci U, De Vincentis A, Santonico M, Pennazza G, Sanguedolce S, De Luca C, Plotti F, Picardi A, Antonelli-Incalzi R. Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study. PLoS One 2020;15:e0233350. [PMID: 32437441 DOI: 10.1371/journal.pone.0233350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
130 Lippi G, Caleffi A, Pipitone S, Elia G, Ngah A, Aloe R, Avanzini P, Ferrari C. Assessment of neutrophil gelatinase-associated lipocalin and lactate dehydrogenase in peritoneal fluids for the screening of bacterial peritonitis. Clinica Chimica Acta 2013;418:59-62. [DOI: 10.1016/j.cca.2012.12.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
131 陈文, 杨春, 毕义亮, 唐黎, 吴刚, 邓存良. 肝再生增强因子在HBV相关肝硬化患者中的表达及意义. 世界华人消化杂志 2014; 22(3): 434-438 [DOI: 10.11569/wcjd.v22.i3.434] [Reference Citation Analysis]
132 Morrison D, Sgrillo J, Daniels LH. Managing alcoholic liver disease. Nursing 2014;44:30-40. [DOI: 10.1097/01.nurse.0000454950.13699.e0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
133 Lo Re V, Lim JK, Goetz MB, Tate J, Bathulapalli H, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf. 2011;20:689-699. [PMID: 21626605 DOI: 10.1002/pds.2148] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 9.5] [Reference Citation Analysis]
134 Barsuk JH, Cohen ER, Vozenilek JA, O'Connor LM, McGaghie WC, Wayne DB. Simulation-based education with mastery learning improves paracentesis skills. J Grad Med Educ 2012;4:23-7. [PMID: 23451302 DOI: 10.4300/JGME-D-11-00161.1] [Cited by in Crossref: 83] [Cited by in F6Publishing: 28] [Article Influence: 10.4] [Reference Citation Analysis]
135 Yim HJ, Suh SJ, Jung YK, Yim SY, Seo YS, Lee YR, Park SY, Jang JY, Kim YS, Kim HS, Kim BI, Um SH. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial. American Journal of Gastroenterology 2018;113:1167-76. [DOI: 10.1038/s41395-018-0168-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
136 Bellot P, Welker MW, Soriano G, von Schaewen M, Appenrodt B, Wiest R, Whittaker S, Tzonev R, Handshiev S, Verslype C, Moench C, Zeuzem S, Sauerbruch T, Guarner C, Schott E, Johnson N, Petrov A, Katzarov K, Nevens F, Zapater P, Such J. Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. J Hepatol. 2013;58:922-927. [PMID: 23318604 DOI: 10.1016/j.jhep.2012.12.020] [Cited by in Crossref: 84] [Cited by in F6Publishing: 50] [Article Influence: 10.5] [Reference Citation Analysis]
137 Elsabaawy MM, Abdelhamid SR, Alsebaey A, Abdelsamee E, Obada MA, Salman TA, Rewisha E. The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction. Clin Mol Hepatol. 2015;21:365-371. [PMID: 26770925 DOI: 10.3350/cmh.2015.21.4.365] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
138 张兴光, 冯志杰. 肝硬化自发性细菌性腹膜炎的诊断及治疗进展. 世界华人消化杂志 2015; 23(3): 388-395 [DOI: 10.11569/wcjd.v23.i3.388] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
139 Krease M, Stroup J, Som M, Shepard B. Fulminant ulcerative colitis complicated by treatment-refractory bacteremia. Proc (Bayl Univ Med Cent) 2016;29:407-8. [PMID: 27695178 DOI: 10.1080/08998280.2016.11929489] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis. World J Gastroenterol. 2009;15:5505-5510. [PMID: 19938187 DOI: 10.3748/wig.15.5505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
141 Costas-rodríguez M, Anoshkina Y, Lauwens S, Van Vlierberghe H, Delanghe J, Vanhaecke F. Isotopic analysis of Cu in blood serum by multi-collector ICP-mass spectrometry: a new approach for the diagnosis and prognosis of liver cirrhosis? Metallomics 2015;7:491-8. [DOI: 10.1039/c4mt00319e] [Cited by in Crossref: 54] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
142 Silva PE, Fayad L, Lazzarotto C, Ronsoni MF, Bazzo ML, Colombo BS, Dantas-Correa EB, Narciso-Schiavon JL, Schiavon LL. Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis. Liver Int. 2015;35:1516-1523. [PMID: 24840673 DOI: 10.1111/liv.12597] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
143 Selim FO, El-deeb NA, Farrag HA, Ahmed AM. Assessment of calprotectin in ascitic fluid as a marker for spontaneous bacterial peritonitis diagnosis in cirrhotic patients. Egypt J Intern Med 2018;30:223-30. [DOI: 10.4103/ejim.ejim_17_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Guo J, Shi J, Wang H, Chen H, Liu S, Li J, Wang Y. Emerging Gram-positive bacteria and drug resistance in cirrhosis patients with spontaneous bacterial peritonitis: A retrospective study. Exp Ther Med 2019;17:4568-76. [PMID: 31186679 DOI: 10.3892/etm.2019.7502] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Carrier P, Jacques J, Debette-gratien M, Legros R, Sarabi M, Vidal E, Sautereau D, Bezanahary H, Ly K, Loustaud-ratti V. L’ascite non liée à la cirrhose : physiopathologie, diagnostic et étiologies. La Revue de Médecine Interne 2014;35:365-71. [DOI: 10.1016/j.revmed.2013.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
146 Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
147 Kawaratani H, Fukui H, Yoshiji H. Treatment for cirrhotic ascites. Hepatol Res. 2017;47:166-177. [PMID: 27363974 DOI: 10.1111/hepr.12769] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
148 Werner KT, Perez ST. Role of Nurse Practitioners in the Management of Cirrhotic Patients. The Journal for Nurse Practitioners 2012;8:816-21. [DOI: 10.1016/j.nurpra.2012.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
149 Hope AA, Morrison RS. Integrating Palliative Care with Chronic Liver Disease Care. J Palliat Care 2011;27:20-7. [DOI: 10.1177/082585971102700105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
150 Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol 2011; 17(10): 1237-1248 [PMID: 21455322 DOI: 10.3748/wjg.v17.i10.1237] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
151 Suraweera D, Jimenez M, Viramontes M, Jamal N, Grotts J, Elashoff D, Lee EW, Saab S. Age-related Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunts. Journal of Clinical Gastroenterology 2017;51:360-3. [DOI: 10.1097/mcg.0000000000000541] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
152 Seidler M, Sayegh K, Roy A, Mesurolle B. A fatal complication of ultrasound-guided abdominal paracentesis. J Clin Ultrasound 2013;41:457-60. [PMID: 23606571 DOI: 10.1002/jcu.22050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
153 Lim N, Lidofsky SD. Impact of physician specialty on quality care for patients hospitalized with decompensated cirrhosis. PLoS One. 2015;10:e0123490. [PMID: 25837700 DOI: 10.1371/journal.pone.0123490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
154 Singhal S, Baikati KK, Jabbour II, Anand S. Management of refractory ascites. Am J Ther. 2012;19:121-132. [PMID: 21192246 DOI: 10.1097/mjt.0b013e3181ff7a8b] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
155 Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13:273-282. [PMID: 23426401 DOI: 10.1038/nrc3432] [Cited by in Crossref: 262] [Cited by in F6Publishing: 268] [Article Influence: 32.8] [Reference Citation Analysis]
156 Wang D, Feng JF, Wang AQ, Yang YW, Liu YS. Role of Cystatin C and glomerular filtration rate in diagnosis of kidney impairment in hepatic cirrhosis patients. Medicine (Baltimore) 2017;96:e6949. [PMID: 28514315 DOI: 10.1097/MD.0000000000006949] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
157 Devarbhavi H, Murali AR. Safety of Ascitic Paracentesis in Patients with Budd-Chiari Syndrome on Oral Anticoagulation and Elevated International Normalized Ratio. J Clin Exp Hepatol 2015;5:310-3. [PMID: 26900272 DOI: 10.1016/j.jceh.2015.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
158 Dibas M, Rajab AM, Zaghloul MS, Atiah MJ, Aljundi S, Amir A, Saquib N. Ascitic calprotectin for the diagnosis of spontaneous bacterial peritonitis: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2020;32:1075-83. [DOI: 10.1097/meg.0000000000001709] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Rogers NA, Gupta S, Cuthbert JA. Continuous furosemide infusion in the management of ascites. J Investig Med 2012;60:671-5. [PMID: 22373660 DOI: 10.2310/JIM.0b013e31824963f1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
160 Tandon P, Kumar D, Seo YS, Chang HJ, Chaulk J, Carbonneau M, Qamar H, Keough A, Mansoor N, Ma M. The 22/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis. Am J Gastroenterol. 2013;108:1473-1479. [PMID: 23877350 DOI: 10.1038/ajg.2013.204] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
161 Lyles T, Elliott A, Rockey DC. A risk scoring system to predict in-hospital mortality in patients with cirrhosis presenting with upper gastrointestinal bleeding. J Clin Gastroenterol. 2014;48:712-720. [PMID: 24172184 DOI: 10.1097/mcg.0000000000000014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
162 Chinnock B, Woolard RE, Hendey GW, Crawford S, Mainis L, Vo D, Wells RN, Ramirez R, Bengiamin DI. Sensitivity of a bedside reagent strip for the detection of spontaneous bacterial peritonitis in ED patients with ascites. Am J Emerg Med 2019;37:2155-8. [PMID: 30737002 DOI: 10.1016/j.ajem.2019.01.044] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
163 Yang YY, Lin HC, Lin MW, Chu CJ, Lee FY, Hou MC, Lee SD, Lee WP, Liu TT, Jap TS. Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites. Clin Sci (Lond) 2011;121:509-21. [PMID: 21692745 DOI: 10.1042/CS20110018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
164 Baldin C, Piedade J, Guimarães L, Victor L, Duarte J, Veiga Z, Alcântara C, Fernandes F, Pereira JL, Pereira G. CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients. Dig Dis Sci 2021. [PMID: 33389350 DOI: 10.1007/s10620-020-06791-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Gilani N, Patel N, Gerkin RD, Ramirez FC, Tharalson EE, Patel K. The safety and feasibility of large volume paracentesis performed by an experienced nurse practitioner. Annals of Hepatology 2009;8:359-63. [DOI: 10.1016/s1665-2681(19)31750-8] [Cited by in Crossref: 13] [Article Influence: 1.1] [Reference Citation Analysis]
166 Shamseya MM, Madkour MA. Rifaximin: A reasonable alternative for norfloxacin in the prevention of spontaneous bacterial peritonitis in patients with HCV-related liver cirrhosis. Alexandria Journal of Medicine 2016;52:219-26. [DOI: 10.1016/j.ajme.2015.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
167 Al-Khafaji A, Huang DT. Critical care management of patients with end-stage liver disease. Crit Care Med 2011;39:1157-66. [PMID: 21336121 DOI: 10.1097/CCM.0b013e318211fdc4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
168 Xiong QF, Zhong YD, Hu ZL, Yang YF. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy. Acta Clin Belg 2015;70:223-5. [PMID: 25510219 DOI: 10.1179/2295333714Y.0000000108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
169 Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: Evidence based treatment. World J Gastroenterol 2014; 20(18): 5442-5460 [PMID: 24833875 DOI: 10.3748/wjg.v20.i18.5442] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 80] [Article Influence: 13.3] [Reference Citation Analysis]
170 Martín–llahí M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, Solá E, Pereira G, Marinelli M, Pavesi M, Fernández J, Rodés J, Arroyo V, Ginès P. Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis. Gastroenterology 2011;140:488-496.e4. [DOI: 10.1053/j.gastro.2010.07.043] [Cited by in Crossref: 217] [Cited by in F6Publishing: 171] [Article Influence: 21.7] [Reference Citation Analysis]
171 Lau JSY, Korman TM, Woolley I. Life-long antimicrobial therapy: where is the evidence? J Antimicrob Chemother 2018;73:2601-12. [PMID: 29873746 DOI: 10.1093/jac/dky174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
172 Chaulk J, Carbonneau M, Qamar H, Keough A, Chang HJ, Ma M, Kumar D, Tandon P. Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies. Can J Gastroenterol Hepatol 2014;28:83-8. [PMID: 24288693 DOI: 10.1155/2014/429536] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
173 Fuster O, Andino B, Pardo A, Laiz B. Continuous ambulatory peritoneal dialysis, ascitic and pleural body fluids evaluation with the Mindray BC-6800 hematology analyzer. J Clin Lab Anal 2018;32. [PMID: 28444939 DOI: 10.1002/jcla.22240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
174 Acevedo J, Silva A, Prado V, Fernández J. The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications. Hepatol Int. 2013;7:72-79. [PMID: 26201623 DOI: 10.1007/s12072-012-9396-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
175 Xu WP, Wang ZR, Zou X, Zhao C, Wang R, Shi PM, Yuan ZL, Yang F, Zeng X, Wang PQ, Sultan S, Zhang Y, Xie WF. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis. J Dig Dis. 2018;19:242-253. [PMID: 29607614 DOI: 10.1111/1751-2980.12596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
176 Poca M, Alvarado-Tapias E, Concepción M, Pérez-Cameo C, Cañete N, Gich I, Romero C, Casas M, Román E, Castells L, Vargas V, Carrión JA, Guarner C, Soriano G. Predictive model of mortality in patients with spontaneous bacterial peritonitis. Aliment Pharmacol Ther 2016;44:629-37. [PMID: 27464682 DOI: 10.1111/apt.13745] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
177 Tapper EB, Baki J, Hummel S, Lok A. Design and rationale of a randomized-controlled trial of home-delivered meals for the management of symptomatic ascites: the SALTYFOOD trial. Gastroenterol Rep (Oxf) 2019;7:146-9. [PMID: 30976428 DOI: 10.1093/gastro/goz005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
178 Cincotta MC, Coffey KC, Moonah SN, Uppal D, Hughes MA. Case Report of Granulicatella adiacens as a Cause of Bacterascites. Case Rep Infect Dis 2015;2015:132317. [PMID: 26618012 DOI: 10.1155/2015/132317] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
179 Nitta H, Beppu T, Itoyama A, Higashi T, Sakamoto K, Nakagawa S, Mima K, Okabe H, Imai K, Hayashi H, Hashimoto D, Chikamoto A, Ishiko T, Baba H. Poor outcomes after hepatectomy in patients with ascites infected by methicillin-resistant staphylococci. J Hepatobiliary Pancreat Sci 2015;22:166-76. [PMID: 25339191 DOI: 10.1002/jhbp.175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
180 Grattagliano I, Ubaldi E, Bonfrate L, Portincasa P. Management of liver cirrhosis between primary care and specialists. World J Gastroenterol 2011; 17(18): 2273-2282 [PMID: 21633593 DOI: 10.3748/wjg.v17.i18.2273] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
181 Carrion AF, Martin P. Keeping Patients with End-Stage Liver Disease Alive While Awaiting Transplant: Management of Complications of Portal Hypertension. Clin Liver Dis 2021;25:103-20. [PMID: 33978573 DOI: 10.1016/j.cld.2020.08.007] [Reference Citation Analysis]
182 Pimentel CF, Lai M. Nutrition Interventions for Chronic Liver Diseases and Nonalcoholic Fatty Liver Disease. Med Clin North Am. 2016;100:1303-1327. [PMID: 27745596 DOI: 10.1016/j.mcna.2016.06.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
183 Webster CRL, Center SA, Cullen JM, Penninck DG, Richter KP, Twedt DC, Watson PJ. ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. J Vet Intern Med 2019;33:1173-200. [PMID: 30844094 DOI: 10.1111/jvim.15467] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
184 Sanglodkar U, Jain M, Vargese J, Kedarisetty C, Venkataraman J. Clinical audit to determine efficacy of daily infusion of low dose of 20% albumin in combination with antibiotics in patients with spontaneous bacterial peritonitis. Clin Exp Hepatol 2019;5:301-7. [PMID: 31893242 DOI: 10.5114/ceh.2019.88774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
185 Maraolo AE, Buonomo AR, Zappulo E, Scotto R, Pinchera B, Gentile I. Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi. RRCT 2019;14:129-35. [DOI: 10.2174/1574887114666181204102516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
186 So M, Yang DY, Bell C, Humar A, Morris A, Husain S. Solid organ transplant patients: are there opportunities for antimicrobial stewardship? Clin Transplant. 2016;30:659-668. [PMID: 26992472 DOI: 10.1111/ctr.12733] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
187 Shah NL, Banaei YP, Hojnowski KL, Cornella SL. Management options in decompensated cirrhosis. Hepat Med 2015;7:43-50. [PMID: 26203291 DOI: 10.2147/HMER.S62463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
188 Chugh K, Agrawal Y, Goyal V, Khatri V, Kumar P. Diagnosing bacterial peritonitis made easy by use of leukocyte esterase dipsticks. Int J Crit Illn Inj Sci 2015;5:32-7. [PMID: 25810962 DOI: 10.4103/2229-5151.152337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
189 Kibrit J, Khan R, Jung BH, Koppe S. Clinical Assessment and Management of Portal Hypertension. Semin Intervent Radiol 2018;35:153-9. [PMID: 30087517 DOI: 10.1055/s-0038-1660793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
190 Han D, Wang R, Yu Y, Sun M, Teschke R, Romeiro FG, Mancuso A, Song T, Peng Z, Han B, Zhou X, Bao W, Li Q, Zheng K, Li Y, Bai Z, Guo X, Qi X. Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis. Evid Based Complement Alternat Med 2018;2018:2989846. [PMID: 29743922 DOI: 10.1155/2018/2989846] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
191 Numan L, Elkafrawy A, Kaddourah O, Brotherton T, Saeed L, Zafar Y, Tomaw A, Foxworth J, Al-Sayyed L. Spontaneous Bacterial Peritonitis: We Are Still Behind. Cureus 2020;12:e7711. [PMID: 32431989 DOI: 10.7759/cureus.7711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Lou J, Cao L, Zhang Q, Jiang D, Yao W, Bao B, Cao Y, Tang Y, Zhang L, Wang K, Dai G. The toxicity and efficacy evaluation of different fractions of Kansui fry-baked with vinegar on Walker-256 tumor-bearing malignant ascites effusion rats and normal rats. Journal of Ethnopharmacology 2018;219:257-68. [DOI: 10.1016/j.jep.2018.03.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
193 Fujita K, Kuroda N, Morishita A, Oura K, Tadokoro T, Nomura T, Yoneyama H, Arai T, Himoto T, Watanabe S, Masaki T. Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection. J Clin Med. 2018;7. [PMID: 30208564 DOI: 10.3390/jcm7090267] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
194 Pérez-reyes E, Rivera-sánchez J, Servín-caamaño A, Pérez-torres E, Abdo-francis J, Higuera-de la Tijera F. Malnutrition is related to a higher frequency of serious complications in patients with cirrhosis. Revista Médica del Hospital General de México 2016;79:11-6. [DOI: 10.1016/j.hgmx.2015.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
195 Noritake K, Unuma K, Nara A, Uchida K, Shiratori T, Watanuki Y, Funakoshi T, Uemura K. Autopsy findings of a patient with rapidly progressive massive ascites caused by alcoholic cirrhosis. Leg Med (Tokyo) 2011;13:148-50. [PMID: 21277247 DOI: 10.1016/j.legalmed.2010.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
196 Rossi A, Melone V, Turco R, Camera L, Bruzzese E, Miele E, Staiano A, Guarino A, Lo Vecchio A. Peritoneal tuberculosis mimicking carcinomatous ascites in a child living in a low prevalence country: a case report. Ital J Pediatr 2020;46:49. [PMID: 32307013 DOI: 10.1186/s13052-020-0816-6] [Reference Citation Analysis]
197 Hsiang JC, Bai WW, Raos Z, Stableforth W, Upton A, Selvaratnam S, Gane EJ, Gerred SJ. Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in South Auckland, New Zealand: Cirrhosis outcomes in New Zealand. Intern Med J 2015;45:160-9. [DOI: 10.1111/imj.12624] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
198 Garcia-tsao G. Ascites. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the Liver and Biliary System. Oxford: Wiley-Blackwell; 2011. pp. 210-33. [DOI: 10.1002/9781444341294.ch10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
199 Bernardi M, Zaccherini G, Caraceni P. Pro: The Role of Albumin in Pre–Liver Transplant Management. Liver Transpl 2019;25:128-34. [DOI: 10.1002/lt.25356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
200 Lesińska M, Hartleb M, Gutkowski K, Nowakowska-Duława E. Procalcitonin and macrophage inflammatory protein-1 beta (MIP-1β) in serum and peritoneal fluid of patients with decompensated cirrhosis and spontaneous bacterial peritonitis. Adv Med Sci 2014;59:52-6. [PMID: 24797975 DOI: 10.1016/j.advms.2013.07.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
201 Cai J, Zhang M, Han T, Jiang HQ. Characteristics of infection and its impact on short-term outcome in patients with acute-on-chronic liver failure. Medicine (Baltimore). 2017;96:e8057. [PMID: 28906399 DOI: 10.1097/md.0000000000008057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
202 Saffouri GB, Wittich CM. 83-year-old man with abdominal swelling and lower extremity edema. Mayo Clin Proc 2013;88:e115-8. [PMID: 24079694 DOI: 10.1016/j.mayocp.2013.03.008] [Reference Citation Analysis]
203 Peeraphatdit T, Gulleen EA, Anderson KB, Chaiteerakij R, Skarda PK. Letter: underutilisation of albumin infusion in high-risk spontaneous bacterial peritonitis. Aliment Pharmacol Ther 2015;42:241-2. [DOI: 10.1111/apt.13252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
204 Northup P, Reutemann B. Management of Coagulation and Anticoagulation in Liver Transplantation Candidates. Liver Transpl 2018;24:1119-32. [DOI: 10.1002/lt.25198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
205 Iida H, Maehira H, Mori H, Maekawa T, Tani M. Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report. Surg Case Rep 2020;6:61. [PMID: 32232601 DOI: 10.1186/s40792-020-00825-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Endo K, Iida T, Yagi S, Yoshizawa A, Fujimoto Y, Ogawa K, Ogura Y, Mori A, Kaido T, Uemoto S. Impact of preoperative uncontrollable hepatic hydrothorax and massive ascites in adult liver transplantation. Surg Today. 2014;44:2293-2299. [PMID: 24509883 DOI: 10.1007/s00595-014-0839-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
207 Mindikoglu AL, Weir MR. Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol. 2013;38:345-354. [PMID: 24107793 DOI: 10.1159/000355540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
208 Abdel-razik A, Eldars W, Elhelaly R, Eldeeb AA, Abdelsalam M, El-wakeel N, Aboulmagd A. Homocysteine: a new diagnostic marker in spontaneous bacterial peritonitis. European Journal of Gastroenterology & Hepatology 2018;30:779-85. [DOI: 10.1097/meg.0000000000001109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 4.3] [Reference Citation Analysis]
209 Muir AJ. Surgical clearance for the patient with chronic liver disease. Clin Liver Dis. 2012;16:421-433. [PMID: 22541707 DOI: 10.1016/j.cld.2012.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
210 Kathpalia P, Bhatia A, Robertazzi S, Ahn J, Cohen SM, Sontag S, Luke A, Durazo-arvizu R, Pillai AA. Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites: Peritoneal drains for refractory ascites. Intern Med J 2015;45:1026-31. [DOI: 10.1111/imj.12843] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
211 Adlakha N, Russo MW. Outcomes After Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients 70 Years and Older. J Clin Med. 2020;9. [PMID: 32023959 DOI: 10.3390/jcm9020381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Orman ES, Hayashi PH. Re: nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst 2013;105:667. [PMID: 23591462 DOI: 10.1093/jnci/djt061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
213 Leung W, Wong F. Medical management of ascites. Expert Opin Pharmacother 2011;12:1269-83. [PMID: 21306283 DOI: 10.1517/14656566.2011.549126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
214 Salerno F, Navickis RJ, Wilkes MM. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol 2013; 11: 123-30. e1. [PMID: 23178229 DOI: 10.1016/j.cgh.2012.11.007] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
215 Kasztelan-Szczerbinska B, Cichoz-Lach H. Refractory ascites-the contemporary view on pathogenesis and therapy. PeerJ 2019;7:e7855. [PMID: 31637125 DOI: 10.7717/peerj.7855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
216 Hingwala J, Whitlock R, Dunsmore S, Armstrong S, Tangri N, Komenda P. Peritoneal Dialysis Catheters to Treat Refractory Non-Malignant Ascites. Perit Dial Int 2017;37:481-2. [DOI: 10.3747/pdi.2016.00282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
217 Nappi JM. A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide. Pharm Pract (Granada) 2013;11:44-50. [PMID: 24155849 DOI: 10.4321/s1886-36552013000100008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
218 Tapper EB, Patwardhan V, Mazer LM, Vaughn B, Piatkowski G, Evenson AR, Malik R. Predictors of negative intraoperative findings at emergent laparotomy in patients with cirrhosis. J Gastrointest Surg 2014;18:1777-83. [PMID: 25091839 DOI: 10.1007/s11605-014-2599-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
219 Smith EZ, Northup PG, Argo CK. Predictors of Mortality in Cirrhosis Inpatients With Clostridium difficile Infection. Journal of Clinical Gastroenterology 2018;52:747-51. [DOI: 10.1097/mcg.0000000000000868] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
220 Dhiman RK, Rana B, Agrawal S, Garg A, Chopra M, Thumburu KK, Khattri A, Malhotra S, Duseja A, Chawla YK. Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial. Gastroenterology 2014;147:1327-1337.e3. [DOI: 10.1053/j.gastro.2014.08.031] [Cited by in Crossref: 180] [Cited by in F6Publishing: 160] [Article Influence: 25.7] [Reference Citation Analysis]
221 Mohan P, Venkataraman J. Prevalence and risk factors for unsuspected spontaneous ascitic fluid infection in cirrhotics undergoing therapeutic paracentesis in an outpatient clinic. Indian J Gastroenterol. 2011;30:221-224. [PMID: 21956818 DOI: 10.1007/s12664-011-0131-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
222 Lippi G, Danese E, Cervellin G, Montagnana M. Laboratory diagnostics of spontaneous bacterial peritonitis. Clin Chim Acta. 2014;430:164-170. [PMID: 24508989 DOI: 10.1016/j.cca.2014.01.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
223 Wolfe KS, Kress JP. Risk of Procedural Hemorrhage. Chest 2016;150:237-46. [PMID: 26836937 DOI: 10.1016/j.chest.2016.01.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
224 Martel-Laferrière V, Wong M, Dieterich DT. HIV/hepatitis C virus-coinfected patients and cirrhosis: how to diagnose it and what to do next? Clin Infect Dis 2014;58:840-7. [PMID: 24178247 DOI: 10.1093/cid/cit714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
225 Thomson MJ, Lok ASF, Tapper EB. Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis. Hepatology 2021;73:2429-40. [PMID: 32911564 DOI: 10.1002/hep.31548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
226 Ellison DH. Clinical Pharmacology in Diuretic Use. Clin J Am Soc Nephrol 2019;14:1248-57. [PMID: 30936153 DOI: 10.2215/CJN.09630818] [Cited by in Crossref: 36] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
227 Facciorusso A, Papagiouvanni I, Cela M, Buccino VR, Sacco R. Comparative efficacy of long-term antibiotic treatments in the primary prophylaxis of spontaneous bacterial peritonitis. Liver Int. 2019;39:1448-1458. [PMID: 30920712 DOI: 10.1111/liv.14109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
228 Salman TA, Edrees AM, El-said HH, El-abd OL, El-azab GI. Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis: . European Journal of Gastroenterology & Hepatology 2016;28:777-85. [DOI: 10.1097/meg.0000000000000635] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Suk KT, Baik SK, Yoon JH, Cheong JY, Paik YH, Lee CH, Kim YS, Lee JW, Kim DJ, Cho SW, Hwang SG, Sohn JH, Kim MY, Kim YB, Kim JG, Cho YK, Choi MS, Kim HJ, Lee HW, Kim SU, Kim JK, Choi JY, Jun DW, Tak WY, Lee BS, Jang BK, Chung WJ, Kim HS, Jang JY, Jeong SW, Kim SG, Kwon OS, Jung YK, Choe WH, Lee JS, Kim IH, Shim JJ, Cheon GJ, Bae SH, Seo YS, Choi DH, Jang SJ; Korean Association for the Study of the Liver. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18:1-21. [PMID: 22511898 DOI: 10.3350/kjhep.2012.18.1.1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 10.4] [Reference Citation Analysis]
230 Moujaess E, Fakhoury M, Assi T, Elias H, El Karak F, Ghosn M, Kattan J. The Therapeutic use of human albumin in cancer patients’ management. Critical Reviews in Oncology/Hematology 2017;120:203-9. [DOI: 10.1016/j.critrevonc.2017.11.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
231 Fernández J, Gustot T. Management of bacterial infections in cirrhosis. Journal of Hepatology 2012;56:S1-S12. [DOI: 10.1016/s0168-8278(12)60002-6] [Cited by in Crossref: 218] [Cited by in F6Publishing: 89] [Article Influence: 24.2] [Reference Citation Analysis]
232 Lalama MA, Saloum Y. Nutrition, fluid, and electrolytes in chronic liver disease. Clin Liver Dis (Hoboken) 2016;7:18-20. [PMID: 31041020 DOI: 10.1002/cld.526] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
233 Hilscher MB, Johnson JN, Cetta F, Driscoll DJ, Poterucha JJ, Sanchez W, Connolly HM, Kamath PS. Surveillance for liver complications after the Fontan procedure: HILSCHER et al. Congenital Heart Disease 2017;12:124-32. [DOI: 10.1111/chd.12446] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
234 Olivera-Martinez M, Sayles H, Vivekanandan R, D' Souza S, Florescu MC. Hepatorenal syndrome: are we missing some prognostic factors? Dig Dis Sci. 2012;57:210-214. [PMID: 21850494 DOI: 10.1007/s10620-011-1861-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
235 Gaduputi V, Tariq H, Chandrala C, Sakam S, Abbas N, Chilimuri S. Computerized Tomography-Guided Paracentesis: An Effective Alternative to Bedside Paracentesis? J Clin Med Res. 2017;9:92-97. [PMID: 28090224 DOI: 10.14740/jocmr2832w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
236 Padia SA, Chewning RH, Kogut MJ, Ingraham CR, Johnson GE, Bhattacharya R, Kwan SW, Monsky WL, Vaidya S, Hippe DS. Outcomes of Locoregional Tumor Therapy for Patients with Hepatocellular Carcinoma and Transjugular Intrahepatic Portosystemic Shunts. Cardiovasc Intervent Radiol. 2015;38:913-921. [PMID: 25373795 DOI: 10.1007/s00270-014-1009-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
237 Anty R, Tonohouan M, Ferrari-Panaia P, Piche T, Pariente A, Anstee QM, Gual P, Tran A. Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients. Clin Transl Gastroenterol. 2014;5:e56. [PMID: 24871371 DOI: 10.1038/ctg.2014.6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
238 Kim M, Dam A, Green J. Common GI Drug Interactions in the Elderly. Curr Treat Options Gastroenterol 2014;12:292-309. [PMID: 25031070 DOI: 10.1007/s11938-014-0024-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
239 Orman ES, Hayashi PH, Bataller R, Barritt AS 4th. Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites. Clin Gastroenterol Hepatol 2014; 12: 496-503. e1. [PMID: 23978348 DOI: 10.1016/j.cgh.2013.08.025] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
240 Aitbaev KA, Murkamilov IT, Fomin VV. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation]. Ter Arkh 2017;89:120-8. [PMID: 28914862 DOI: 10.17116/terarkh2017898120-128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
241 Lazzarotto C, Ronsoni MF, Fayad L, Nogueira CL, Bazzo ML, Narciso-schiavon JL, Schiavon LDL, Dantas-corrêa EB. Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis. Annals of Hepatology 2013;12:431-9. [DOI: 10.1016/s1665-2681(19)31344-4] [Cited by in Crossref: 26] [Article Influence: 3.3] [Reference Citation Analysis]
242 Egerod Israelsen M, Gluud LL, Krag A. Acute kidney injury and hepatorenal syndrome in cirrhosis. J Gastroenterol Hepatol 2015;30:236-43. [PMID: 25160511 DOI: 10.1111/jgh.12709] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
243 Haberl J, Zollner G, Fickert P, Stadlbauer V. To salt or not to salt?-That is the question in cirrhosis. Liver Int. 2018;38:1148-1159. [PMID: 29608812 DOI: 10.1111/liv.13750] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
244 Moore CM, Van Thiel DH. Cirrhotic ascites review: Pathophysiology, diagnosis and management. World J Hepatol 2013; 5(5): 251-263 [PMID: 23717736 DOI: 10.4254/wjh.v5.i5.251] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
245 Phillip V, Saugel B, Ernesti C, Hapfelmeier A, Schultheiß C, Thies P, Mayr U, Schmid RM, Huber W. Effects of paracentesis on hemodynamic parameters and respiratory function in critically ill patients. BMC Gastroenterol. 2014;14:18. [PMID: 24467993 DOI: 10.1186/1471-230X-14-18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
246 Wang J, Khan S, Wyer P, Vanderwilp J, Reynolds J, Bethancourt B, Ota KS. The Role of Ultrasound-Guided Therapeutic Paracentesis in an Outpatient Transitional Care Program: A Case Series. Am J Hosp Palliat Care 2018;35:1256-60. [DOI: 10.1177/1049909118755378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
247 Fagan KJ, Zhao EY, Horsfall LU, Ruffin BJ, Kruger MS, McPhail SM, O'Rourke P, Ballard E, Irvine KM, Powell EE. Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change? Intern Med J. 2014;44:865-872. [PMID: 24893971 DOI: 10.1111/imj.12491] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
248 Alsebaey A, Abdel-razek W, Bassuni A, Rewisha E, Khalil M, Waked I. Prevention of paracentesis-induced circulatory dysfunction: could we use other albumin alternatives? Egyptian Liver Journal 2013;3:118-25. [DOI: 10.1097/01.elx.0000433597.15423.45] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
249 Kim JH, Jeon YD, Jung IY, Ahn MY, Ahn HW, Ahn JY, Ku NS, Han SH, Choi JY, Ahn SH, Song YG, Han KH, Kim JM. Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis. Medicine (Baltimore). 2016;95:e3489. [PMID: 27124049 DOI: 10.1097/md.0000000000003489] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
250 Tariq T, Irfan FB, Farishta M, Dykstra B, Sieloff EM, Desai AP. Spontaneous fungal peritonitis: Micro-organisms, management and mortality in liver cirrhosis-A systematic review. World J Hepatol 2019; 11(7): 596-606 [PMID: 31388401 DOI: 10.4254/wjh.v11.i7.596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
251 Haep N, Florentino RM, Squires JE, Bell A, Soto-Gutierrez A. The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone. Semin Liver Dis 2021;41:213-24. [PMID: 33992030 DOI: 10.1055/s-0041-1725023] [Reference Citation Analysis]
252 Vilar‐gomez E, Vuppalanchi R, Gawrieh S, Ghabril M, Saxena R, Cummings OW, Chalasani N. Vitamin E Improves Transplant‐Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis. Hepatology 2019;71:495-509. [DOI: 10.1002/hep.30368] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 23.0] [Reference Citation Analysis]
253 Huang YW, Yang SS, Kao JH. Pathogenesis and management of alcoholic liver cirrhosis: a review. Hepat Med 2011;3:1-11. [PMID: 24367215 DOI: 10.2147/HMER.S10265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
254 Bhat G, Vandana KE, Bhatia S, Suvarna D, Pai CG. Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy. Indian J Gastroenterol 2013;32:297-301. [PMID: 23515981 DOI: 10.1007/s12664-013-0329-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
255 Araujo AD, Alvares-da-silva MR. Akin criteria as a predictor of mortality in cirrhotic patients after spontaneous bacterial peritonitis. Annals of Hepatology 2014;13:390-5. [DOI: 10.1016/s1665-2681(19)30870-1] [Cited by in Crossref: 8] [Article Influence: 1.1] [Reference Citation Analysis]
256 Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. Eur J Gastroenterol Hepatol. 2016;28:e10-e18. [PMID: 26671516 DOI: 10.1097/meg.0000000000000548] [Cited by in Crossref: 47] [Cited by in F6Publishing: 17] [Article Influence: 9.4] [Reference Citation Analysis]
257 Bezjak M, Kocman B, Jadrijević S, Gašparović H, Mrzljak A, Kanižaj TF, Vujanić D, Bubalo T, Mikulić D. Constrictive pericarditis as a cause of refractory ascites after liver transplantation: A case report. WJCC 2019;7:3267-70. [DOI: 10.12998/wjcc.v7.i20.3267] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
258 Enomoto H, Inoue S, Matsuhisa A, Nishiguchi S. Diagnosis of spontaneous bacterial peritonitis and an in situ hybridization approach to detect an "unidentified" pathogen. Int J Hepatol 2014;2014:634617. [PMID: 25132996 DOI: 10.1155/2014/634617] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
259 Reinglas J, Amjadi K, Petrcich B, Momoli F, Shaw-Stiffel T. The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX (©) Catheter. Can J Gastroenterol Hepatol 2016;2016:4680543. [PMID: 27446840 DOI: 10.1155/2016/4680543] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
260 Saffo S, To UK, Santoiemma PP, Laurito M, Haque L, Rabiee A, Verna EC, Angarone MP, Garcia-Tsao G. Changes in Ascitic Fluid Polymorphonuclear Cell Count After Antibiotics Are Associated With Mortality in Spontaneous Bacterial Peritonitis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00750-3. [PMID: 34273564 DOI: 10.1016/j.cgh.2021.07.019] [Reference Citation Analysis]
261 Lerschmacher O, Koch A, Streetz K, Trautwein C, Tacke F. [Management of decompensated liver cirrhosis in the intensive care unit]. Med Klin Intensivmed Notfmed. 2013;108:646-656. [PMID: 24030843 DOI: 10.1007/s00063-013-0259-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
262 Yan L, Xie F, Lu J, Ni Q, Shi C, Tang C, Yang J. The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2015;15:65. [PMID: 26054761 DOI: 10.1186/s12876-015-0297-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
263 Porrett PM, Baranov E, ter Horst M. Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list. Transplantation 2015;99:158-63. [PMID: 25050469 DOI: 10.1097/TP.0000000000000299] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
264 Muhie OA. Causes and Clinical Profiles of Ascites at University of Gondar Hospital, Northwest Ethiopia: Institution-Based Cross-Sectional Study. Can J Gastroenterol Hepatol 2019;2019:5958032. [PMID: 31360695 DOI: 10.1155/2019/5958032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
265 Kelil T, Shyn PB, Wu LE, Levesque VM, Kacher D, Khorasani R, Silverman SG. Wall suction-assisted image-guided therapeutic paracentesis: a safe and less expensive alternative to evacuated bottles. Abdom Radiol 2016;41:1333-7. [DOI: 10.1007/s00261-016-0634-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
266 Chiba M, Katayama K, Takeda R, Morita R, Iwahashi K, Onishi Y, Kita H, Nishio A, Kanno T, Saito T. Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine. Hepatol Res. 2013;43:365-373. [PMID: 22994500 DOI: 10.1111/j.1872-034x.2012.01093.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
267 El-Desoki Mahmoud EI, Abdelaziz DH, Abd-Elsalam S, Mansour NO. Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial. Front Pharmacol 2021;12:675948. [PMID: 34276366 DOI: 10.3389/fphar.2021.675948] [Reference Citation Analysis]
268 Zhu LC, Xu L, He WH, Wu W, Zhu X. A quick screening model for symptomatic bacterascites in cirrhosis. Saudi J Gastroenterol 2016;22:282-7. [PMID: 27488322 DOI: 10.4103/1319-3767.187600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
269 Liu F, Rong X, Guo H, Xu D, Liu C, Meng L, Yang X, Guo T, Kan X, Song Y. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC Gastroenterol 2020;20:30. [PMID: 32019495 DOI: 10.1186/s12876-020-1180-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
270 Soriano G, Esparcia O, Montemayor M, Guarner-Argente C, Pericas R, Torras X, Calvo N, Román E, Navarro F, Guarner C. Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis. Aliment Pharmacol Ther. 2011;33:275-284. [PMID: 21083594 DOI: 10.1111/j.1365-2036.2010.04506.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
271 Hayashi PH, Chalasani NP. Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided? CMAJ 2012;184:1555-6. [PMID: 22891207 DOI: 10.1503/cmaj.121270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
272 Baki J, Brown P, Tapper EB. Do Nutritional Interventions Improve the Outcomes of Patients with Cirrhosis and Ascites: A Systematic Review of Randomized Trials. Curr Hepatol Rep 2020;19:71-7. [PMID: 33473347 DOI: 10.1007/s11901-020-00513-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
273 Enomoto H, Inoue SI, Matsuhisa A, Iwata Y, Aizawa N, Sakai Y, Takata R, Ikeda N, Hasegawa K, Nakano C, Nishimura T, Yoh K, Miyamoto Y, Ishii N, Yuri Y, Ishii A, Takashima T, Nishikawa H, Iijima H, Nishiguchi S. Amplification of bacterial genomic DNA from all ascitic fluids with a highly sensitive polymerase chain reaction. Mol Med Rep 2018;18:2117-23. [PMID: 29901148 DOI: 10.3892/mmr.2018.9159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 Ahmed AM, Kadaru AG, Omer I, Musa AM, Enan K, El Khidir IM, Williams R. Macrophages from patients with cirrhotic ascites showed function alteration of host defense receptor. J Clin Exp Hepatol 2014;4:279-86. [PMID: 25755574 DOI: 10.1016/j.jceh.2014.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
275 Jafri S, Gordon SC. Care of the Cirrhotic Patient. Infectious Disease Clinics of North America 2012;26:979-94. [DOI: 10.1016/j.idc.2012.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
276 Solà E, Ginès P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol 2010;53:1135-45. [PMID: 20850887 DOI: 10.1016/j.jhep.2010.08.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
277 Cholongitas E, Karatapanis S, Nakouti T, Birtsou C, Skorda L, Kouvelis I, Papastergiou V, Papachrysos N, Goulis J, Akriviadis E. Can 24-h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis? Liver Int 2012;32:172-3. [DOI: 10.1111/j.1478-3231.2011.02669.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
278 Saunders J, Brian A, Wright M, Stroud M. Malnutrition and nutrition support in patients with liver disease. Frontline Gastroenterol. 2010;1:105-111. [PMID: 28839557 DOI: 10.1136/fg.2009.000414] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
279 Enomoto H, Inoue S, Matsuhisa A, Aizawa N, Imanishi H, Saito M, Iwata Y, Tanaka H, Ikeda N, Sakai Y, Takashima T, Shimomura S, Iijima H, Nakamura H, Nishiguchi S. Development of a new in situ hybridization method for the detection of global bacterial DNA to provide early evidence of a bacterial infection in spontaneous bacterial peritonitis. Journal of Hepatology 2012;56:85-94. [DOI: 10.1016/j.jhep.2011.06.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
280 Baijal R, Amarapurkar D, Praveen Kumar HR, Kulkarni S, Shah N, Doshi S, Gupta D, Jain M, Patel N, Kamani P, Issar SK, Dharod M, Shah A, Chandnani M, Gautam S. A multicenter prospective study of infections related morbidity and mortality in cirrhosis of liver. Indian J Gastroenterol 2014;33:336-42. [DOI: 10.1007/s12664-014-0461-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
281 Northup PG, Friedman LS, Kamath PS. AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review. Clin Gastroenterol Hepatol. 2019;17:595-606. [PMID: 30273751 DOI: 10.1016/j.cgh.2018.09.043] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 14.7] [Reference Citation Analysis]
282 Lunel-Fabiani F, Masson C, Ducancelle A. Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivation. Joint Bone Spine. 2014;81:478-484. [PMID: 24561021 DOI: 10.1016/j.jbspin.2014.01.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
283 Macdonald S, Jalan R. Editorial: alfapump-an alternative to large-volume paracentesis for patients with refractory ascites? Aliment Pharmacol Ther 2018;47:139-40. [DOI: 10.1111/apt.14390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
284 Adachi T, Takeuchi Y, Takaki A, Oyama A, Wada N, Onishi H, Shiraha H, Okada H. Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan. Int J Mol Sci 2021;22:5582. [PMID: 34070416 DOI: 10.3390/ijms22115582] [Reference Citation Analysis]
285 Fagundes C, Ginès P. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis. Am J Kidney Dis. 2012;59:874-885. [PMID: 22480795 DOI: 10.1053/j.ajkd.2011.12.032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
286 Buoro S, Mecca T, Azzarà G, Seghezzi M, Candiago E, Gianatti A, Crippa A, La Gioia A. Mindray BC-6800 body fluid mode, performance of nucleated cells, and differential count in ascitic and pleural fluids. Int Jnl Lab Hem 2016;38:90-101. [DOI: 10.1111/ijlh.12446] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
287 MacIntosh T. Emergency Management of Spontaneous Bacterial Peritonitis - A Clinical Review. Cureus 2018;10:e2253. [PMID: 29721399 DOI: 10.7759/cureus.2253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
288 Brode SK, Ling SC, Chapman KR. Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ 2012;184:1365-71. [PMID: 22761482 DOI: 10.1503/cmaj.111749] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
289 Spinella R, Sawhney R, Jalan R. Albumin in chronic liver disease: structure, functions and therapeutic implications. Hepatol Int. 2016;10:124-132. [PMID: 26420218 DOI: 10.1007/s12072-015-9665-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 8.7] [Reference Citation Analysis]
290 Mattos AA, Costabeber AM, Lionço LC, Tovo CV. Multi-resistant bacteria in spontaneous bacterial peritonitis: A new step in management? World J Gastroenterol 2014; 20(39): 14079-14086 [PMID: 25339797 DOI: 10.3748/wjg.v20.i39.14079] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
291 Correa CG, Colombo BDS, Ronsoni MF, Soares e Silva PE, Fayad L, Silva TE, Wildner LM, Bazzo ML, Dantas-Correa EB, Narciso-Schiavon JL, Schiavon LL. Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis. World J Hepatol 2016; 8(17): 739-748 [PMID: 27330683 DOI: 10.4254/wjh.v8.i17.739] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
292 Namba M, Hiramatsu A, Aikata H, Kodama K, Uchikawa S, Ohya K, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Tsuge M, Imamura M, Chayama K. Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis. J Gastroenterol 2020;55:217-26. [PMID: 31485782 DOI: 10.1007/s00535-019-01623-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
293 Rogers GB, Russell LE, Preston PG, Marsh P, Collins JE, Saunders J, Sutton J, Fine D, Bruce KD, Wright M. Characterisation of bacteria in ascites--reporting the potential of culture-independent, molecular analysis. Eur J Clin Microbiol Infect Dis. 2010;29:533-541. [PMID: 20238135 DOI: 10.1007/s10096-010-0891-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
294 Krajina A, Hulek P, Fejfar T, Valek V. Quality improvement guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS). Cardiovasc Intervent Radiol. 2012;35:1295-1300. [PMID: 23070105 DOI: 10.1007/s00270-012-0493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
295 Vicco MH, Rodeles L, Ferini F, Long AK, Musacchio HM. In-hospital mortality risk factors in patients with ascites due to cirrhosis. Rev Assoc Med Bras (1992) 2015;61:35-9. [PMID: 25909206 DOI: 10.1590/1806-9282.61.01.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
296 Costabeber AM, Mattos AA, Sukiennik TC. Prevalence of bacterial resistance in hospitalized cirrhotic patients in southern brazil: a new challenge. Rev Inst Med Trop Sao Paulo. 2016;58:36. [PMID: 27253738 DOI: 10.1590/s1678-9946201658036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
297 De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, Gerunda GE, di Benedetto F, Garcia-Tsao G, Villa E. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial. Hepatology. 2016;63:566-573. [PMID: 26340411 DOI: 10.1002/hep.28148] [Cited by in Crossref: 210] [Cited by in F6Publishing: 166] [Article Influence: 35.0] [Reference Citation Analysis]
298 Rowe IA, Parker R, Armstrong MJ, King AL, Houlihan DD, Mutimer D. Assessment of the Quality of Evidence Underlying International Guidelines in Liver Disease. American Journal of Gastroenterology 2012;107:1276-82. [DOI: 10.1038/ajg.2012.71] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
299 Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: An updated meta-analysis. World J Gastroenterol 2014; 20(10): 2704-2714 [PMID: 24627607 DOI: 10.3748/wjg.v20.i10.2704] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 49] [Article Influence: 9.9] [Reference Citation Analysis]
300 Frazee EN, Leedahl DD, Kashani KB. Key Controversies in Colloid and Crystalloid Fluid Utilization. Hosp Pharm 2015;50:446-53. [PMID: 26405334 DOI: 10.1310/hpj5006-446] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
301 Sharma P, Goodrich NP, Zhang M, Guidinger MK, Schaubel DE, Merion RM. Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol. 2013;8:1135-1142. [PMID: 23449770 DOI: 10.2215/cjn.09600912] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 6.1] [Reference Citation Analysis]
302 Johnson TM, Overgard EB, Cohen AE, Dibaise JK. Nutrition Assessment and Management in Advanced Liver Disease. Nutr Clin Pract 2013;28:15-29. [DOI: 10.1177/0884533612469027] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 11.3] [Reference Citation Analysis]
303 Barsuk JH, Cohen ER, Feinglass J, McGaghie WC, Wayne DB. Clinical outcomes after bedside and interventional radiology paracentesis procedures. Am J Med 2013;126:349-56. [PMID: 23398950 DOI: 10.1016/j.amjmed.2012.09.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
304 Ferreira da Silva AC, Cunha-Silva M, Ferraz Mazo D, Mana MF, Vicente de Paula R, de Ataíde EC, Boin IFSF, Stucchi RSB, Sevá-Pereira T. Cryptococcal peritonitis in patients on the liver transplant waitlist: Reporting two cases with opposite outcomes. Transpl Infect Dis 2021;:e13583. [PMID: 33583111 DOI: 10.1111/tid.13583] [Reference Citation Analysis]
305 Kamal F, Khan MA, Khan Z, Cholankeril G, Hammad TA, Lee WM, Ahmed A, Waters B, Howden CW, Nair S, Satapathy SK. Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2017;29:1109-17. [DOI: 10.1097/meg.0000000000000940] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 3.8] [Reference Citation Analysis]
306 Ford RM, Sakaria SS, Subramanian RM. Critical care management of patients before liver transplantation. Transplant Rev (Orlando) 2010;24:190-206. [PMID: 20688502 DOI: 10.1016/j.trre.2010.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
307 White A. Outpatient interventions for hepatology patients with fluid retention: a review and synthesis of the literature. Gastroenterol Nurs 2014;37:236-44. [PMID: 24871669 DOI: 10.1097/SGA.0000000000000051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
308 Afshar M, Netzer G. Update in critical care for the nephrologist: transfusion in nonhemorrhaging critically ill patients. Adv Chronic Kidney Dis 2013;20:30-8. [PMID: 23265594 DOI: 10.1053/j.ackd.2012.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
309 Mellinger JL, Volk ML. Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin Gastroenterol Hepatol. 2013;11:217-223. [PMID: 23142204 DOI: 10.1016/j.cgh.2012.10.040] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
310 Malli E, Gatselis NK, Dalekos GN, Petinaki E. Combination of vial culture and broad-range PCR for the diagnosis of spontaneous bacterial peritonitis: experience in a Greek tertiary care hospital. New Microbes New Infect 2019;28:1-5. [PMID: 30671251 DOI: 10.1016/j.nmni.2018.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
311 Nguyen VQ, Gadiraju TV, Patel H, Park M, Le Jemtel TH, Jaiswal A. Intra-abdominal Hypertension: An Important Consideration for Diuretic Resistance in Acute Decompensated Heart Failure. Clin Cardiol 2016;39:37-40. [PMID: 26687765 DOI: 10.1002/clc.22489] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
312 Wallace JA, Hussain J, Unzueta A, Morelli G. Pasteurella multocida Bacteremia and Peritonitis in a Patient With Cirrhosis: A Life-Threatening Case From a Prick of a Cactus. J Investig Med High Impact Case Rep 2017;5:2324709617726103. [PMID: 28890902 DOI: 10.1177/2324709617726103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
313 Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med 2014;20:352-7. [PMID: 24811830 DOI: 10.1097/MCP.0000000000000058] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
314 Estébanez-Montiel MB, Quintana-Díaz M, García de Lorenzo y Mateos A, Blancas Gomez-Casero R, Acosta-Escribano J, Marcos-Neira P; Transfusions and Blood Products and Metabolism and Nutrition work groups of Spanish Society of Intensive Care and Coronary Units (Sociedad Española de Medicina Intensiva y Unidades Coronarias, SEMICYUC). Results of a survey on albumin use in clinical practice in intensive care units. Med Intensiva 2014;38:403-12. [PMID: 24183619 DOI: 10.1016/j.medin.2013.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
315 Jindal A, Kumar M, Bhadoria AS, Maiwall R, Sarin SK. A randomized open label study of ‘imipenem vs. cefepime’ in spontaneous bacterial peritonitis. Liver Int. 2016;36:677-687. [PMID: 26474358 DOI: 10.1111/liv.12985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
316 Liu F, Kong X, Dou Q, Ye J, Xu D, Shang H, Xu K, Song Y. Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites. Ann Hepatol. 2014;13:357-363. [PMID: 24756011 DOI: 10.1016/s1665-2681(19)30865-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
317 Liaw YF, Raptopoulou-Gigi M, Cheinquer H, Sarin SK, Tanwandee T, Leung N, Peng CY, Myers RP, Brown RS Jr, Jeffers L, Tsai N, Bialkowska J, Tang S, Beebe S, Cooney E. Efficacy and safety of entecavir vs adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study. Hepatology. 2011;54:91-100. [PMID: 21503940 DOI: 10.1002/hep.24361] [Cited by in Crossref: 143] [Cited by in F6Publishing: 130] [Article Influence: 14.3] [Reference Citation Analysis]
318 Garioud A, Cadranel J, Pauwels A, Nousbaum J, Thévenot T, Dao T, Louvet A, Sogni P, Talbodec N, Antonini TM, Bureau C, Thabut D, Elkrief L, Jouannaud V, Macaigne G, Bernard-chabert B, Lison H, Alric L, Carbonell N, Labadie H, Amiot X, Abergel A, Hanslik B, Leroy V, De Lédinghen V, Denis J. Albumin Use in Patients With Cirrhosis in France: Results of the “ALBU-LIVE” Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. Journal of Clinical Gastroenterology 2017;51:831-8. [DOI: 10.1097/mcg.0000000000000735] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
319 Shriver AR, Rudnick SR, Intagliata NM, Wang AM, Caldwell SH, Northup PG. A Randomized Controlled Trial of Procedural Techniques for Large Volume Paracentesis. Annals of Hepatology 2017;16:279-84. [DOI: 10.5604/16652681.1231589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
320 Ferrarese A, Tikhonoff V, Casiglia E, Angeli P, Fasolato S, Faggian D, Zanetto A, Germani G, Russo FP, Burra P, Senzolo M. Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites. Gastroenterol Res Pract 2018;2018:4098210. [PMID: 29861720 DOI: 10.1155/2018/4098210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
321 Snoga JL, Lusk KA, Attridge RT, Attridge RL. Effect of Nonselective β-Blockers on Mortality in Patients With End-Stage Cirrhosis. Ann Pharmacother 2020;54:322-30. [PMID: 31701773 DOI: 10.1177/1060028019886529] [Reference Citation Analysis]
322 Kozeniecki M, Ludke R, Kerner J, Patterson B. Micronutrients in Liver Disease: Roles, Risk Factors for Deficiency, and Recommendations for Supplementation.Nutr Clin Pract. 2020;35:50-62. [PMID: 31840874 DOI: 10.1002/ncp.10451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
323 Wong KA, Olson KA, Chak EW. An Unusual Cause of Abdominal Ascites. Case Rep Gastroenterol 2018;12:420-4. [PMID: 30186094 DOI: 10.1159/000490660] [Reference Citation Analysis]
324 Caly WR, Abreu RM, Bitelman B, Carrilho FJ, Ono SK. Clinical Features of Refractory Ascites in Outpatients. Clinics (Sao Paulo). 2017;72:405-410. [PMID: 28792999 DOI: 10.6061/clinics/2017(07)03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
325 Simonetti RG, Perricone G, Nikolova D, Bjelakovic G, Gluud C. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. Cochrane Database Syst Rev 2019;6:CD004039. [PMID: 31251387 DOI: 10.1002/14651858.CD004039.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
326 Zhang Y, Lou J, Kang A, Zhang Q, Zhou S, Bao B, Cao Y, Yao W, Tang Y, Zhang L. Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions. Journal of Ethnopharmacology 2020;249:112423. [DOI: 10.1016/j.jep.2019.112423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
327 Na SH, Kim EJ, Nam EY, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Park SW, Kim HB, Oh MD, Kim NJ. Comparison of clinical characteristics and outcomes of spontaneous bacterial peritonitis and culture negative neutrocytic ascites. Scand J Gastroenterol. 2017;52:199-203. [PMID: 27797274 DOI: 10.1080/00365521.2016.1245776] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
328 Maruyama H, Kondo T, Kiyono S, Sekimoto T, Takahashi M, Yokosuka O. Influence of splenorenal shunt on long-term outcomes in cirrhosis. Scand J Gastroenterol. 2015;50:593-600. [PMID: 25635924 DOI: 10.3109/00365521.2014.1003401] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
329 Strauss E. The impact of bacterial infections on survival of patients with decompensated cirrhosis. Annals of Hepatology 2014;13:7-19. [DOI: 10.1016/s1665-2681(19)30899-3] [Cited by in Crossref: 19] [Article Influence: 2.7] [Reference Citation Analysis]
330 Hu J, Wang T, Zhang KH, Jiang YP, Xu S, Chen SH, He YT, Yuan HL, Wang YQ. Pretreatment risk management of a novel nomogram model for prediction of thoracoabdominal extrahepatic metastasis in primary hepatic carcinoma. J Transl Med 2019;17:117. [PMID: 30961629 DOI: 10.1186/s12967-019-1861-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
331 Poca M, Concepción M, Casas M, Alvarez-Urturi C, Gordillo J, Hernández-Gea V, Román E, Guarner-Argente C, Gich I, Soriano G. Role of albumin treatment in patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2012;10:309-315. [PMID: 22094025 DOI: 10.1016/j.cgh.2011.11.012] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
332 Caraceni P, Tufoni M, Bonavita ME. Clinical use of albumin. Blood Transfus 2013;11 Suppl 4:s18-25. [PMID: 24333308 DOI: 10.2450/2013.005s] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
333 Alessandria C, Elia C, Mezzabotta L, Risso A, Andrealli A, Spandre M, Morgando A, Marzano A, Rizzetto M. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study. Dig Liver Dis. 2011;43:881-886. [PMID: 21741331 DOI: 10.1016/j.dld.2011.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
334 Garbuzenko DV, Arefyev NO. Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol 2019; 25(28): 3738-3752 [PMID: 31391769 DOI: 10.3748/wjg.v25.i28.3738] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
335 Kanai Y, Ishiki H, Maeda I, Iwase S. A survey of practice in management of malignancy-related ascites in Japan. PLoS One 2019;14:e0220869. [PMID: 31398238 DOI: 10.1371/journal.pone.0220869] [Reference Citation Analysis]
336 Yim SY, Seo YS, Jung CH, Kim TH, Kim ES, Keum B, Kim JH, An H, Yim HJ, Yeon JE, Jeen YT, Lee HS, Chun HJ, Byun KS, Um SH, Kim CD, Ryu HS. Risk Factors for Developing Hyponatremia during Terlipressin Treatment: A Retrospective Analyses in Variceal Bleeding. J Clin Gastroenterol. 2015;49:607-612. [PMID: 25216384 DOI: 10.1097/mcg.0000000000000217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
337 Kockerling D, Nathwani R, Forlano R, Manousou P, Mullish BH, Dhar A. Current and future pharmacological therapies for managing cirrhosis and its complications. World J Gastroenterol 2019; 25(8): 888-908 [PMID: 30833797 DOI: 10.3748/wjg.v25.i8.888] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 10] [Article Influence: 10.5] [Reference Citation Analysis]
338 Njei B, McCarty TR, Laine L. Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding. J Gastroenterol Hepatol 2017;32:852-8. [PMID: 27624167 DOI: 10.1111/jgh.13593] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
339 Ferrarese A, Passigato N, Cusumano C, Gemini S, Tonon A, Dajti E, Marasco G, Ravaioli F, Colecchia A. Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice. World J Hepatol 2021; 13(8): 840-852 [PMID: 34552691 DOI: 10.4254/wjh.v13.i8.840] [Reference Citation Analysis]
340 Piroth L, Pechinot A, Di Martino V, Hansmann Y, Putot A, Patry I, Hadou T, Jaulhac B, Chirouze C, Rabaud C. Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study. BMC Infect Dis. 2014;14:287. [PMID: 24884471 DOI: 10.1186/1471-2334-14-287] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
341 黄华兰, 聂鑫, 贺勇, 吴斌, 宋昊岚, 罗通行, 杨正兵, 高宝秀, 李贵星. 内毒素和前列腺素I2/血栓素A2与1型肝肾综合征的关系. 世界华人消化杂志 2013; 21(29): 3132-3138 [DOI: 10.11569/wcjd.v21.i29.3132] [Reference Citation Analysis]
342 Chang TS, Tsai YH, Lin YH, Chen CH, Lu CK, Huang WS, Yang YH, Chen WM, Hsieh YY, Wu YC, Tung SY, Huang YH. Limited effects of antibiotic prophylaxis in patients with Child-Pugh class A/B cirrhosis and upper gastrointestinal bleeding. PLoS One 2020;15:e0229101. [PMID: 32084186 DOI: 10.1371/journal.pone.0229101] [Reference Citation Analysis]
343 Marques de Sá I, Bibi M, Moura M, Carvalhana S, Cortez-Pinto H. No evidence of benefit of routine ascitic fluid analysis in refractory ascites undergoing therapeutic paracentesis. Eur J Gastroenterol Hepatol 2021;33:942. [PMID: 33908390 DOI: 10.1097/MEG.0000000000002119] [Reference Citation Analysis]
344 Tsochatzis EA, Bosch J, Burroughs AK. Prolonging survival in patients with cirrhosis: old drugs with new indications. Gastroenterology. 2010;139:1813-1815.e1. [PMID: 21034779 DOI: 10.1053/j.gastro.2010.10.031] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
345 Ariza X, Lora-tamayo J, Castellote J, Xiol X, Ariza J. Polymorphonuclear counts in ascitic fluid and microorganisms producing spontaneous bacterial peritonitis: an under-recognized relationship. Scandinavian Journal of Gastroenterology 2013;48:1213-21. [DOI: 10.3109/00365521.2013.832367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
346 Sandhaus LM. Body Fluid Cell Counts by Automated Methods. Clinics in Laboratory Medicine 2015;35:93-103. [DOI: 10.1016/j.cll.2014.10.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
347 de Wit K, Schaapman JJ, Nevens F, Verbeek J, Coenen S, Cuperus FJC, Kramer M, Tjwa ETTL, Mostafavi N, Dijkgraaf MGW, van Delden OM, Beuers UHW, Coenraad MJ, Takkenberg RB. Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial). BMJ Open Gastroenterol 2020;7:e000531. [PMID: 33372103 DOI: 10.1136/bmjgast-2020-000531] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Addolorato G, Vassallo GA, Mirijello A, Gasbarrini A. Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows. Neurotherapeutics 2020;17:127-41. [PMID: 31713188 DOI: 10.1007/s13311-019-00802-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
349 Day R, Hollywood C, Durrant D, Perkins P. Patient experience of non-malignant ascites and its treatment: a qualitative study. Int J Palliat Nurs 2015;21:372-9. [PMID: 26312532 DOI: 10.12968/ijpn.2015.21.8.372] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
350 Northup P, Davis J. Shortcomings in Design and Analysis of Clinical Studies on Bleeding and Thrombosis in Patients with Cirrhosis. Semin Thromb Hemost 2020;46:665-72. [PMID: 32757183 DOI: 10.1055/s-0040-1714203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
351 Guo TT, Yang Y, Song Y, Ren Y, Liu ZX, Cheng G. Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis. J Dig Dis. 2016;17:11-19. [PMID: 26630543 DOI: 10.1111/1751-2980.12304] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
352 Zhang J, Rössle M, Zhou X, Deng J, Liu L, Qi X. Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence. Current Medical Research and Opinion 2019;35:859-68. [DOI: 10.1080/03007995.2018.1552575] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
353 Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, Ridola L, Attili AF, Venditti M. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol. 2010;8:979-985. [PMID: 20621200 DOI: 10.1016/j.cgh.2010.06.024] [Cited by in Crossref: 198] [Cited by in F6Publishing: 182] [Article Influence: 18.0] [Reference Citation Analysis]
354 Polli F, Gattinoni L. Balancing volume resuscitation and ascites management in cirrhosis. Curr Opin Anaesthesiol 2010;23:151-8. [PMID: 20124894 DOI: 10.1097/ACO.0b013e32833724da] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
355 Dever JB, Sheikh MY. Review article: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther. 2015;41:1116-1131. [PMID: 25819304 DOI: 10.1111/apt.13172] [Cited by in Crossref: 83] [Cited by in F6Publishing: 60] [Article Influence: 13.8] [Reference Citation Analysis]
356 Solà E, Solé C, Ginès P. Management of uninfected and infected ascites in cirrhosis. Liver Int 2016;36 Suppl 1:109-15. [PMID: 26725907 DOI: 10.1111/liv.13015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
357 Mah A, Wright A. Infectious Considerations in the Pre-Transplant Evaluation of Cirrhotic Patients Awaiting Orthotopic Liver Transplantation. Curr Infect Dis Rep. 2016;18:4. [PMID: 26743200 DOI: 10.1007/s11908-015-0514-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
358 Yang X, Ru S, Luo L, Lv X, Bai W, Zhang F, Jiang F. Efficacy and safety of umbilical therapy with the traditional Chinese medicine formulation Lishui Xiaogu cataplasm for cirrhotic ascites: protocol for a randomized controlled trial. Trials 2019;20:127. [PMID: 30760320 DOI: 10.1186/s13063-019-3221-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
359 Casadaban LC, Gaba RC. Percutaneous Portosystemic Shunts: TIPS and Beyond. Semin Intervent Radiol 2014;31:227-34. [PMID: 25177082 DOI: 10.1055/s-0034-1382789] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
360 Lehto TM, Leskinen P, Hedberg P, Vaskivuo TE. Evaluation of the Sysmex XT-4000 i for the automated body fluid analysis. Int Jnl Lab Hem 2014;36:114-23. [DOI: 10.1111/ijlh.12134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
361 Thevenot T, Degand T, Grelat N, Elkrief L, Christol C, Moreau R, Henrion J, Cadranel JF, Sheppard F, Bureau C, di Martino V, Pauwels A;  National Association of General Hospital Hepatogastroenterologists. A French national survey on the use of antibiotic prophylaxis in cirrhotic patients. Liver Int. 2013;33:389-397. [PMID: 23302021 DOI: 10.1111/liv.12093] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
362 Feng Y, Chen CL, Chen TH, Liang YH, Chen HL, Lin CY, Chiu CH. Application of next-generation sequencing to study ascitic microbiome in cirrhotic patients with or without spontaneous bacterial peritonitis. J Microbiol Immunol Infect. 2014;Epub ahead of print. [PMID: 25305707 DOI: 10.1016/j.jmii.2014.07.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
363 Anand G, Zarrinpar A, Loomba R. Targeting Dysbiosis for the Treatment of Liver Disease. Semin Liver Dis. 2016;36:37-47. [PMID: 26870931 DOI: 10.1055/s-0035-1571276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
364 Watts MR, Gupta V, Liddle C. Antimicrobials in Cirrhotic Patients After Upper Gastrointestinal Hemorrhage: One Size No Longer Fits All. Clinical Gastroenterology and Hepatology 2016;14:324-5. [DOI: 10.1016/j.cgh.2015.07.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
365 Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55:1172-1181. [PMID: 22095893 DOI: 10.1002/hep.24786] [Cited by in Crossref: 194] [Cited by in F6Publishing: 143] [Article Influence: 21.6] [Reference Citation Analysis]
366 Piano S, Tonon M, Angeli P. Management of ascites and hepatorenal syndrome. Hepatol Int 2018;12:122-34. [DOI: 10.1007/s12072-017-9815-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
367 Enescu A, Petrescu F, Mitruţ P, Petrescu IO, Pădureanu V, Enescu AŞ. Hepatorenal Syndrome: Diagnosis and Treatment - newsreel. Rom J Intern Med 2016;54:143-50. [PMID: 27658161 DOI: 10.1515/rjim-2016-0024] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
368 Lee S, Saxinger L, Ma M, Prado V, Fernández J, Kumar D, Gonzalez-Abraldes J, Keough A, Bastiampillai R, Carbonneau M, Fernandez J, Tandon P. Bacterial infections in acute variceal hemorrhage despite antibiotics-a multicenter study of predictors and clinical impact. United European Gastroenterol J 2017;5:1090-9. [PMID: 29238587 DOI: 10.1177/2050640617704564] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
369 Zhu S, Du L, Xu D, Lu Z, Xu T, Li J, Xu K, Ye J, Song Y. Ascitic fluid total protein, a useful marker in non-portal hypertensive ascites. J Gastroenterol Hepatol 2020;35:271-7. [PMID: 31247673 DOI: 10.1111/jgh.14768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
370 Lichvar AB, Hedges A, Benedict NJ, Donihi AC. Combination of a Flipped Classroom Format and a Virtual Patient Case to Enhance Active Learning in a Required Therapeutics Course. Am J Pharm Educ 2016;80:175. [PMID: 28179724 DOI: 10.5688/ajpe8010175] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
371 Rickard BP, Conrad C, Sorrin AJ, Ruhi MK, Reader JC, Huang SA, Franco W, Scarcelli G, Polacheck WJ, Roque DM, Del Carmen MG, Huang HC, Demirci U, Rizvi I. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response. Cancers (Basel) 2021;13:4318. [PMID: 34503128 DOI: 10.3390/cancers13174318] [Reference Citation Analysis]
372 Sekiguchi H, Suzuki J, Daniels CE. Making Paracentesis Safer. Chest 2013;143:1136-9. [DOI: 10.1378/chest.12-0871] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
373 Tan H, Martin P. Care of the Liver Transplant Candidate. Clinics in Liver Disease 2011;15:779-806. [DOI: 10.1016/j.cld.2011.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
374 Gerbes AL, Jüngst D. Role of cholesterol determination in ascitic fluid analysis. Hepatology 2009;50:1320. [PMID: 19790086 DOI: 10.1002/hep.23213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
375 Simonetto DA, Gines P, Kamath PS. Hepatorenal syndrome: pathophysiology, diagnosis, and management.BMJ. 2020;370:m2687. [PMID: 32928750 DOI: 10.1136/bmj.m2687] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
376 Ngamruengphong S, Nugent K, Rakvit A, Parupudi S. Potential preventability of spontaneous bacterial peritonitis. Dig Dis Sci. 2011;56:2728-2734. [PMID: 21394460 DOI: 10.1007/s10620-011-1647-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
377 Fernández J, Acevedo J, Castro M, Garcia O, Rodríguez de Lope C, Roca D, Pavesi M, Sola E, Moreira L, Silva A, Seva-pereira T, Corradi F, Mensa J, Ginès P, Arroyo V. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study. Hepatology 2012;55:1551-61. [DOI: 10.1002/hep.25532] [Cited by in Crossref: 341] [Cited by in F6Publishing: 281] [Article Influence: 37.9] [Reference Citation Analysis]
378 Bal CK, Daman R, Bhatia V. Predictors of fifty days in-hospital mortality in decompensated cirrhosis patients with spontaneous bacterial peritonitis. World J Hepatol 2016; 8(12): 566-572 [PMID: 27134704 DOI: 10.4254/wjh.v8.i12.566] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
379 Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014; 20(10): 2542-2554 [PMID: 24627590 DOI: 10.3748/wjg.v20.i10.2542] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 61] [Article Influence: 10.3] [Reference Citation Analysis]
380 Jain P. Spontaneous bacterial peritonitis: Few additional points. World J Gastroenterol 2009; 15(45): 5754-5755 [PMID: 19960577 DOI: 10.3748/wjg.15.5754] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
381 Dundar HZ, Yılmazlar T. Management of hepatorenal syndrome. World J Nephrol 2015; 4(2): 277-286 [PMID: 25949942 DOI: 10.5527/wjn.v4.i2.277] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
382 Engelman D, Moreau M, Lepida A, Zaouak Y, Paesmans M, Awada A. Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity. ESMO Open 2020;5:e000695. [PMID: 32487541 DOI: 10.1136/esmoopen-2020-000695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
383 Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance. World J Hepatol 2016; 8(6): 307-321 [PMID: 26962397 DOI: 10.4254/wjh.v8.i6.307] [Cited by in Crossref: 97] [Cited by in F6Publishing: 79] [Article Influence: 19.4] [Reference Citation Analysis]
384 Arroyo V, Fernández J. Management of hepatorenal syndrome in patients with cirrhosis. Nat Rev Nephrol 2011;7:517-26. [DOI: 10.1038/nrneph.2011.96] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
385 Al-Busafi SA, Ghali P, Deschênes M, Wong P. Chylous Ascites: Evaluation and Management. ISRN Hepatol 2014;2014:240473. [PMID: 27335837 DOI: 10.1155/2014/240473] [Cited by in Crossref: 58] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
386 Sancho-Bru P, Altamirano J, Rodrigo-Torres D, Coll M, Millán C, José Lozano J, Miquel R, Arroyo V, Caballería J, Ginès P, Bataller R. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology 2012;55:1931-41. [PMID: 22278680 DOI: 10.1002/hep.25614] [Cited by in Crossref: 123] [Cited by in F6Publishing: 118] [Article Influence: 13.7] [Reference Citation Analysis]
387 Sakaida I, Yanase M, Kobayashi Y, Yasutake T, Okada M, Okita K; ASCITES Clinical Pharmacology Group. The pharmacokinetics and pharmacodynamics of tolvaptan in patients with liver cirrhosis with insufficient response to conventional diuretics: a multicentre, double-blind, parallel-group, phase III study. J Int Med Res 2012;40:2381-93. [PMID: 23321196 DOI: 10.1177/030006051204000637] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
388 Sofjan AK, Musgrove RJ, Beyda ND, Russo HP, Lasco TM, Yau R, Restrepo A, Garey KW. Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA. J Glob Antimicrob Resist 2018;15:41-7. [PMID: 29842975 DOI: 10.1016/j.jgar.2018.05.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
389 Barsuk JH, Cohen ER, Feinglass J, Kozmic SE, Mcgaghie WC, Ganger D, Wayne DB. Cost Savings of Performing Paracentesis Procedures at the Bedside After Simulation-based Education. Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare 2014;9:312-8. [DOI: 10.1097/sih.0000000000000040] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 5.4] [Reference Citation Analysis]
390 Fowler C. Management of patients with complications of cirrhosis. The Nurse Practitioner 2013;38:14-22. [DOI: 10.1097/01.npr.0000427610.76270.45] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
391 Yang Y, Li L, Qu C, Zeng B, Liang S, Luo Z, Wang X, Zhong C. Diagnostic Accuracy of Serum Procalcitonin for Spontaneous Bacterial Peritonitis Due to End-stage Liver Disease: A Meta-analysis. Medicine (Baltimore). 2015;94:e2077. [PMID: 26656333 DOI: 10.1097/md.0000000000002077] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
392 Tsochatzis EA, Bosch J, Burroughs AK. New therapeutic paradigm for patients with cirrhosis. Hepatology. 2012;56:1983-1992. [PMID: 22729954 DOI: 10.1002/hep.25915] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 10.5] [Reference Citation Analysis]
393 Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH, Book W, Gurvitz M, John A, John B, Marelli A, Marino BS, Minich LL, Poterucha JJ, Rand EB, Veldtman GR. Fontan-Associated Liver Disease. Journal of the American College of Cardiology 2017;70:3173-94. [DOI: 10.1016/j.jacc.2017.10.045] [Cited by in Crossref: 91] [Cited by in F6Publishing: 70] [Article Influence: 22.8] [Reference Citation Analysis]
394 Higuera-de-la-Tijera F, Servín-Caamaño AI, Salas-Gordillo F, Pérez-Hernández JL, Abdo-Francis JM, Camacho-Aguilera J, Alla SN, Jiménez-Ponce F. Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding. Can J Gastroenterol Hepatol 2018;2018:3015891. [PMID: 30079329 DOI: 10.1155/2018/3015891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
395 Fimiani B, Guardia DD, Puoti C, D’Adamo G, Cioffi O, Pagano A, Tagliamonte MR, Izzi A. The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study. Eur J Intern Med. 2011;22:587-590. [PMID: 22075285 DOI: 10.1016/j.ejim.2011.06.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
396 Wong F, Bendel E, Sniderman K, Frederick T, Haskal ZJ, Sanyal A, Asrani SK, Capel J, Kamath PS. Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump. Liver Transpl 2020;26:651-61. [PMID: 31999044 DOI: 10.1002/lt.25724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
397 Sheasgreen C, Lu L, Patel A. Pathophysiology, diagnosis, and management of hepatic encephalopathy. Inflammopharmacol 2014;22:319-26. [DOI: 10.1007/s10787-014-0217-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
398 Tijera FHDL, Servín-Caamaño AI, Serralde-Zúñiga AE, Cruz-Herrera J, Pérez-Torres E, Abdo-Francis JM, Salas-Gordillo F, Pérez-Hernández JL. Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis. World J Gastroenterol 2015; 21(16): 4975-4985 [PMID: 25945012 DOI: 10.3748/wjg.v21.i16.4975] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
399 Husbands EL. Targeting Diuretic Use for Malignant Ascites—Two Case Reports Highlighting the Value of the Serum-Ascites Albumin Gradient in a Palliative Setting. Journal of Pain and Symptom Management 2010;39:e7-9. [DOI: 10.1016/j.jpainsymman.2009.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
400 Mazer L, Tapper EB, Piatkowski G, Lai M. The need for antibiotic stewardship and treatment standardization in the care of cirrhotic patients with spontaneous bacterial peritonitis - a retrospective cohort study examining the effect of ceftriaxone dosing. F1000Res. 2014;3:57. [PMID: 25165535 DOI: 10.12688/f1000research.3-57.v2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
401 石光英, 袁泽, 杨丽丽, 谢敬东. 奥曲肽治疗肝硬化合并顽固性腹水的Meta分析. 世界华人消化杂志 2015; 23(27): 4411-4417 [DOI: 10.11569/wcjd.v23.i27.4411] [Reference Citation Analysis]
402 Tu B, Zhang YN, Bi JF, Xu Z, Zhao P, Shi L, Zhang X, Yang G, Qin EQ. Multivariate predictive model for asymptomatic spontaneous bacterial peritonitis in patients with liver cirrhosis. World J Gastroenterol 2020; 26(29): 4316-4326 [PMID: 32848336 DOI: 10.3748/wjg.v26.i29.4316] [Reference Citation Analysis]
403 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications. Clin Mol Hepatol 2018;24:230-77. [PMID: 29991196 DOI: 10.3350/cmh.2018.1005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
404 Pleguezuelo M, Benitez JM, Jurado J, Montero JL, De la Mata M. Diagnosis and management of bacterial infections in decompensated cirrhosis. World J Hepatol 2013; 5(1): 16-25 [PMID: 23383362 DOI: 10.4254/wjh.v5.i1.16] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
405 Hoekstra LT, Wakkie T, Busch OR, Gouma DJ, Beuers U, van Gulik T. Predictors of posthepatectomy ascites with or without previous portal vein embolization. Dig Surg 2012;29:468-74. [PMID: 23296107 DOI: 10.1159/000345583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
406 Acharya C, Bajaj JS. Current Management of Hepatic Encephalopathy. Am J Gastroenterol. 2018;113:1600-1612. [PMID: 30002466 DOI: 10.1038/s41395-018-0179-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
407 Fernandez J, Arroyo V. Bacterial Infections in Cirrhosis: A Growing Problem with Significant Implications. Clin Liver Dis. 2013;2:102-105. [PMID: 30992836 DOI: 10.1002/cld.169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
408 Bucsics T, Krones E. Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome. Gastroenterol Rep (Oxf). 2017;5:127-137. [PMID: 28533910 DOI: 10.1093/gastro/gox009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
409 Chinese Society of Hepatology, Chinese Medical Association. Xu X, Duan Z, Ding H, Li W, Jia J, Wei L, Linghu E, Zhuang H. Chinese guidelines on the management of ascites and its related complications in cirrhosis. Hepatol Int. 2019;13:1-21. [PMID: 30656520 DOI: 10.1007/s12072-018-09923-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
410 Cai Q, Liu W, Zhu M, Sheng J. Microbial Infections as a Trigger for Acute-on-Chronic Liver Failure: A Review. Med Sci Monit 2019;25:4773-83. [PMID: 31282874 DOI: 10.12659/MSM.915637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
411 Huang YF, Lin CS, Cherng YG, Yeh CC, Chen RJ, Chen TL, Liao CC. A population-based cohort study of mortality of intensive care unit patients with liver cirrhosis. BMC Gastroenterol 2020;20:15. [PMID: 31948392 DOI: 10.1186/s12876-020-1163-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
412 Kanwal F, Kramer J, Asch SM, El-Serag H, Spiegel BM, Edmundowicz S, Sanyal AJ, Dominitz JA, McQuaid KR, Martin P, Keeffe EB, Friedman LS, Ho SB, Durazo F, Bacon BR. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010;8:709-717. [PMID: 20385251 DOI: 10.1016/j.cgh.2010.03.028] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 8.3] [Reference Citation Analysis]
413 Wong F. Management of ascites in cirrhosis. J Gastroenterol Hepatol. 2012;27:11-20. [PMID: 21916992 DOI: 10.1111/j.1440-1746.2011.06925.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
414 Sundaram V, Manne V, Al-Osaimi AM. Ascites and spontaneous bacterial peritonitis: recommendations from two United States centers. Saudi J Gastroenterol. 2014;20:279-287. [PMID: 25253362 DOI: 10.4103/1319-3767.141686] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
415 Leung DH, Narkewicz MR. Cystic Fibrosis-related cirrhosis. Journal of Cystic Fibrosis 2017;16:S50-61. [DOI: 10.1016/j.jcf.2017.07.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
416 Confer BD, Lopez R, Zein NN. CD4+ T-Cell function and the risk for developing spontaneous bacterial peritonitis in patients with cirrhosis. J Clin Gastroenterol 2013;47:807-13. [PMID: 23507764 DOI: 10.1097/MCG.0b013e3182854969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
417 Urrunaga NH, Singal AG, Cuthbert JA, Rockey DC. Hemorrhagic ascites. Clinical presentation and outcomes in patients with cirrhosis. J Hepatol. 2013;58:1113-1118. [PMID: 23348236 DOI: 10.1016/j.jhep.2013.01.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
418 Huang M, Feng Z, Ji D, Cao Y, Shi X, Chen P, Wang P, Tang M, Liu K. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study. Cytotherapy. 2014;16:1575-1583. [PMID: 25287603 DOI: 10.1016/j.jcyt.2014.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
419 Chua H, Baldwin I, Bailey M, Subramaniam A, Bellomo R. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure. Journal of Critical Care 2012;27:744.e7-744.e15. [DOI: 10.1016/j.jcrc.2012.08.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
420 Shu C, Wang J, Wang J, Yu C, Lee L. Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis. Clinical Microbiology and Infection 2012;18:246-52. [DOI: 10.1111/j.1469-0691.2011.03547.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
421 Wong F, O'Leary JG, Reddy KR, Patton H, Kamath PS, Fallon MB, Garcia-Tsao G, Subramanian RM, Malik R, Maliakkal B, Thacker LR, Bajaj JS;  North American Consortium for Study of End-Stage Liver Disease. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology 2013; 145: 1280-8. e1. [PMID: 23999172 DOI: 10.1053/j.gastro.2013.08.051] [Cited by in Crossref: 150] [Cited by in F6Publishing: 132] [Article Influence: 18.8] [Reference Citation Analysis]
422 Atwell TD, Wennberg PW, Mcmenomy BP, Murthy NS, Anderson JR, Kriegshauser JS, Mckinney JM. Peri-procedural use of anticoagulants in radiology: an evidence-based review. Abdom Radiol 2017;42:1556-65. [DOI: 10.1007/s00261-016-1027-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
423 van de Geijn GM, van Gent M, van Pul-bom N, Beunis MH, van Tilburg AJP, Njo TL. A new flow cytometric method for differential cell counting in ascitic fluid: Ascites Differential Cell Counting by Flow Cytometry. Cytometry 2016;90:506-11. [DOI: 10.1002/cyto.b.21171] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
424 Desai AP, Reau N, Reddy KG, Te HS, Mohanty S, Satoskar R, Devoss A, Jensen D. Persistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver disease. Therap Adv Gastroenterol. 2012;5:275-283. [PMID: 22973414 DOI: 10.1177/1756283x11417037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
425 Zhang C, Zhao L, Ding Y, Sheng Q, Bai H, An Z, Xia T, Wang J, Dou X. Enhanced LL-37 expression following vitamin D supplementation in patients with cirrhosis and spontaneous bacterial peritonitis. Liver Int 2016;36:68-75. [DOI: 10.1111/liv.12888] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
426 Solà E, Sanchez-Cabús S, Rodriguez E, Elia C, Cela R, Moreira R, Pose E, Sánchez-Delgado J, Cañete N, Morales-Ruiz M, Campos F, Balust J, Guevara M, García-Valdecasas JC, Ginès P. Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites. Liver Transpl 2017;23:583-93. [PMID: 28318147 DOI: 10.1002/lt.24763] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
427 李文渊, 叶超, 高鹏飞, 朱肖鸿. HBV相关慢性肝衰竭发生自发性腹膜炎的危险因素. 世界华人消化杂志 2015; 23(1): 134-138 [DOI: 10.11569/wcjd.v23.i1.134] [Reference Citation Analysis]
428 Norvell JP, Spivey JR. Hepatic hydrothorax. Clin Liver Dis. 2014;18:439-449. [PMID: 24679505 DOI: 10.1016/j.cld.2014.01.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
429 Johnson KB, Campbell EJ, Chi H, Zheng H, King LY, Wu Y, Delemos A, Hurairah A, Corey K, Richter JM. Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort. Dig Dis Sci. 2014;59:174-182. [PMID: 23990035 DOI: 10.1007/s10620-013-2832-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
430 Hiramine Y, Uto H, Imamura Y, Hiwaki T, Kure T, Ijuin S, Oda K, Mawatari S, Kumagai K, Tokunaga K, Higashi H, Kanetsuki I, Kubozono O, Maenohara S, Ido A. Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema. Hepatol Res 2017;47:542-57. [PMID: 27448501 DOI: 10.1111/hepr.12778] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
431 Enomoto H, Inoue S, Matsuhisa A, Nishiguchi S. Diagnosis of spontaneous bacterial peritonitis and an in situ hybridization approach to detect an "unidentified" pathogen. Int J Hepatol. 2014;2014:634617. [PMID: 25132996 DOI: 10.1155/2014/] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
432 邵茉莉, 刘冰熔. 肝硬化腹水形成机制的研究现状. 世界华人消化杂志 2013; 21(2): 160-165 [DOI: 10.11569/wcjd.v21.i2.160] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
433 Burri E, Schulte F, Muser J, Meier R, Beglinger C. Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count. World J Gastroenterol 2013; 19(13): 2028-2036 [PMID: 23599621 DOI: 10.3748/wjg.v19.i13.2028] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
434 Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, Kamath PS. Congenital heart disease and the liver. Hepatology 2012;56:1160-9. [DOI: 10.1002/hep.25692] [Cited by in Crossref: 132] [Cited by in F6Publishing: 102] [Article Influence: 14.7] [Reference Citation Analysis]
435 Campbell SJ, Bechara R, Islam S. Point-of-Care Ultrasound in the Intensive Care Unit. Clin Chest Med 2018;39:79-97. [PMID: 29433727 DOI: 10.1016/j.ccm.2017.11.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
436 Fayad L, Narciso-schiavon JL, Lazzarotto C, Ronsoni MF, Wildner LM, Bazzo ML, Schiavon LDL, Dantas-corrêa EB. The performance of prognostic models as predictors of mortality in patients with acute decompensation of cirrhosis. Annals of Hepatology 2015;14:83-92. [DOI: 10.1016/s1665-2681(19)30804-x] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
437 Moon H, Kim HJ, Woo SM, Park IH, Sim SH. Discrimination of ascitic fluid infection in malignant ascites by polymorphonuclear neutrophil ratio and count: Investigating the validity of count ≥250/mm3 as the one-size-fits-all criterion. Asia Pac J Clin Oncol 2021;17:e87-93. [PMID: 32762145 DOI: 10.1111/ajco.13344] [Reference Citation Analysis]
438 Wang RR, Gu HQ, Wei YY, Yang JX, Hou YX, Liu HM, Yang ZY, Wang XB, Jiang YY. Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis. J Clin Transl Hepatol 2021;9:647-54. [PMID: 34722179 DOI: 10.14218/JCTH.2021.00031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
439 Uojima H, Hidaka H, Nakayama T, Sung JH, Ichita C, Tokoro S, Masuda S, Sasaki A, Koizumi K, Egashira H, Kako M. Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study. World J Gastroenterol 2017; 23(45): 8062-8072 [PMID: 29259382 DOI: 10.3748/wjg.v23.i45.8062] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
440 黄茂涛, 曹亚玲, 冯早明, 季代金, 张文华, 史小英, 王平, 汤敏, 谭瓛, 谢永祥, 赵睿婷. TIPS联合自体骨髓干细胞移植治疗失代偿期肝硬化. 世界华人消化杂志 2013; 21(30): 3275-3280 [DOI: 10.11569/wcjd.v21.i30.3275] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
441 Guillaume M, Robic M, Péron J, Selves J, Otal P, Sirach E, Vinel J, Bureau C. Clinical characteristics and outcome of cirrhotic patients with high protein concentrations in ascites: a prospective study. European Journal of Gastroenterology & Hepatology 2016;28:1268-74. [DOI: 10.1097/meg.0000000000000697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
442 Kanwal F, Kramer JR, Buchanan P, Asch SM, Assioun Y, Bacon BR, Li J, El-Serag HB. The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology. 2012;143:70-77. [PMID: 22465432 DOI: 10.1053/j.gastro.2012.03.038] [Cited by in Crossref: 106] [Cited by in F6Publishing: 84] [Article Influence: 11.8] [Reference Citation Analysis]
443 Bureau C, Adebayo D, Chalret de Rieu M, Elkrief L, Valla D, Peck-Radosavljevic M, McCune A, Vargas V, Simon-Talero M, Cordoba J, Angeli P, Rosi S, MacDonald S, Malago M, Stepanova M, Younossi ZM, Trepte C, Watson R, Borisenko O, Sun S, Inhaber N, Jalan R. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study. J Hepatol 2017;67:940-9. [PMID: 28645737 DOI: 10.1016/j.jhep.2017.06.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 35] [Article Influence: 13.3] [Reference Citation Analysis]
444 Radmand R, Schilsky M, Jakab S, Khalaf M, Falace DA. Pre-liver transplant protocols in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115:426-30. [PMID: 23522643 DOI: 10.1016/j.oooo.2012.12.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
445 Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: A severe complication of liver cirrhosis. World J Gastroenterol 2009; 15(44): 5505-5510 [PMID: 19938187 DOI: 10.3748/wjg.15.5505] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
446 Potts JR, Goubet S, Heneghan MA, Verma S. Determinants of long-term outcome in severe alcoholic hepatitis. Aliment Pharmacol Ther 2013;38:584-95. [PMID: 23879720 DOI: 10.1111/apt.12427] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
447 Cholongitas E, Goulis J, Arsos G, Birtsou C, Nakouti T, Papadopoulou S, Chalevas P, Karakatsanis K, Akriviadis E. Association between ratio of sodium to potassium in random urine samples and renal dysfunction and mortality in patients with decompensated cirrhosis. Clin Gastroenterol Hepatol. 2013;11:862-867. [PMID: 23403009 DOI: 10.1016/j.cgh.2013.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
448 Ito D, Akamatsu N, Togashi J, Kaneko J, Arita J, Hasegawa K, Sakamoto Y, Kokudo N. Behavior and clinical impact of ascites after living donor liver transplantation: risk factors associated with massive ascites: Behavior and clinical impact of ascites after living donor liver transplantation: risk factors associated with massive ascites. J Hepatobiliary Pancreat Sci 2016;23:688-96. [DOI: 10.1002/jhbp.390] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
449 Fiore M, Leone S. Spontaneous fungal peritonitis: Epidemiology, current evidence and future prospective. World J Gastroenterol 2016; 22(34): 7742-7747 [PMID: 27678356 DOI: 10.3748/wjg.v22.i34.7742] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
450 Du L, Zhu S, Lu Z, Xu T, Bai T, Xu D, Wei X, Li J, Xu K, Ye J, Hou X, Song Y. Ascitic cholesterol is superior to serum-ascites albumin gradient in the detection of non-portal hypertensive ascites and the diagnosis of mixed ascites. Aliment Pharmacol Ther 2019;49:91-8. [PMID: 30443960 DOI: 10.1111/apt.15042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
451 Liu XQ, Zhang XY, Ying Y, Zheng JM, Sun J, Zhang WH, Zhang JM, Huang YX. The role of prophylactic antibiotics in hepatitis B virus-related acute-on-chronic liver failure patients at risk of bacterial infection: a retrospective study. Infect Dis Poverty 2021;10:44. [PMID: 33789759 DOI: 10.1186/s40249-021-00830-7] [Reference Citation Analysis]
452 Pedersen JS, Bendtsen F, Møller S. Management of cirrhotic ascites. Ther Adv Chronic Dis 2015;6:124-37. [PMID: 25954497 DOI: 10.1177/2040622315580069] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
453 Uojima H, Kinbara T, Hidaka H, Sung JH, Ichida M, Tokoro S, Masuda S, Takizawa S, Sasaki A, Koizumi K, Egashira H, Kako M. Close correlation between urinary sodium excretion and response to tolvaptan in liver cirrhosis patients with ascites: Correlated factors to tolvaptan in liver cirrhosis. Hepatol Res 2017;47:E14-21. [DOI: 10.1111/hepr.12716] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]